Parkinson's disease, including avohilmo

G6_PARKINSON_INCLAVO

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — G20 1 out of 7 registries used, show all original rules.	3143
4. Check minimum number of events None	3143
5. Include endpoints G6_PARKINSON	6231
6. Filter based on genotype QC (FinnGen only)	6231

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	G6_PARKINSON_INCLAVO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_PARKINSON
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	G20
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Parkinson's disease, including avohilmo based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6231	2489	3742
Unadjusted period prevalence (%)	1.33	0.85	1.65
Median age at first event (years)	69.58	68.32	70.41

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5510: Matched controls
55094

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N04BD02

ATC

rasagiline; oral

3321.3

323.0

879

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

469.2

323.0

4053

325

193

Kela drug reimbursment

Rasagiline

+∞

323.0

709

N87

ICPC

Parkinsonism

343.7

323.0

1428

N04BX02

ATC

entacapone; oral

+∞

323.0

413

N04BC09

ATC

rotigotine; transdermal

215.7

323.0

363

N04AA02

ATC

biperiden; systemic

20.5

323.0

530

284

G20

ICD-10 Finland

Parkinson disease

+∞

323.0

4854

N04BC04

ATC

ropinirole; oral

196.7

323.0

1052

N06DA03

ATC

rivastigmine; oral, transdermal

7.5

323.0

829

1263

N04BD01

ATC

selegiline; oral

639.9

323.0

1797

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

+∞

323.0

4443

R25.1

ICD-10 Finland

Tremor, unspecified

19.6

323.0

946

576

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

+∞

323.0

563

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

50.6

323.0

577

127

N04BC05

ATC

pramipexole; oral

12.9

323.0

1858

2091

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

4841.9

323.0

1188

N05AH04

ATC

quetiapine; oral

4.4

321.7

1371

3869

N03AE01

ATC

clonazepam; systemic

5.3

213.8

707

1476

AAG20

NOMESCO Finland

Stereotactic intracranial implantation of electrodes

293.2

194.4

197

N04BB01

ATC

amantadine; oral

13.6

190.9

342

267

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.6

180.2

681

1628

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

62.6

180.1

211

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.9

154.4

697

1957

C07AA05

ATC

propranolol; systemic

2.7

150.4

1189

5015

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

122.6

143.8

155

F02.39

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

711.0

141.5

139

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

67.1

140.7

163

G04BD12

ATC

mirabegron; oral

2.9

138.4

964

3734

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

87.6

129.8

145

H02AA02

ATC

fludrocortisone; oral

16.1

126.7

210

135

G25.0

ICD-10 Finland

Essential tremor

6.1

122.3

352

608

3320A

ICD-9 Finland

Parkinson's disease, Paralysis agitans

+∞

117.1

112

R53

ICD-10 Finland

Malaise and fatigue

2.2

115.8

1424

7439

N05AH03

ATC

olanzapine; systemic

4.5

115.4

437

1029

A06AD11

ATC

lactulose; oral

2.3

114.6

1270

6312

F20.9

ICD-10 Finland

Schizophrenia, unspecified

9.4

111.4

239

265

A28

ICPC

Limited function/disability NOS

2.2

108.6

1327

6879

I95.1

ICD-10 Finland

Orthostatic hypotension

3.9

103.8

456

1232

AA1AD

NOMESCO Finland

CT of head and brain

2.0

102.1

1737

10315

N04BC02

ATC

pergolide; oral

254.6

98.0

100

SPAT1229

SPAT

Assessment of need for aid

2.7

95.4

734

2968

N05AH02

ATC

clozapine; systemic

11.8

93.8

178

156

XF606

NOMESCO Finland

Ortostatic test

13.2

93.5

168

131

L28

ICPC

Limited function/disability (L)

2.1

90.9

1209

6433

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.9

90.7

604

2229

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.1

90.5

536

1828

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

89.2

1942

12473

N04BC06

ATC

cabergoline; oral (dopamine agonists)

30.9

83.4

112

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

8.9

82.9

182

210

N06AX11

ATC

mirtazapine; oral

1.9

81.8

1726

10888

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

81.0

1190

6556

G23.1

ICD-10 Finland

Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

83.2

80.2

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

79.7

1766

11306

N05AF03

ATC

chlorprothixene; systemic

5.9

78.1

230

407

N05AX08

ATC

risperidone; systemic

2.7

78.1

610

2470

XA800

NOMESCO Finland

Neuropsychological investigation

4.3

78.1

304

731

SPAT1216

SPAT

Assessment of functional ability

2.0

77.3

1169

6501

N05AA02

ATC

levomepromazine; systemic

3.8

73.6

336

933

N05BA04

ATC

oxazepam; oral

1.9

73.3

1421

8637

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

29.6

73.1

G25.2

ICD-10 Finland

Other specified forms of tremor

15.8

73.0

121

N03AG01

ATC

valproic acid; systemic, rectal

3.3

71.2

393

1267

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

2.8

68.1

479

1816

N05AF05

ATC

zuclopenthixol; systemic

10.2

67.9

138

139

G02CB01

ATC

bromocriptine; systemic

12.1

67.8

126

106

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

6.9

67.5

174

258

N06AB10

ATC

escitalopram; oral

2.1

64.6

838

4341

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.8

64.6

465

1785

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.3

63.8

342

1078

29599

ICD-8 Finland

Schizophrenia, Unspecified type

15.1

63.5

107

SPAT1234

SPAT

Support of social functional capacity

2.8

63.3

446

1689

G21.8

ICD-10 Finland

Other secondary parkinsonism

43.9

63.0

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

62.8

1193

7136

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

61.6

929

5106

N05AC02

ATC

thioridazine; oral

5.3

61.4

194

374

R4130

NOMESCO Finland

Speech therapy

4.5

60.7

223

506

N29

ICPC

Neurological sympt/complt other

5.1

60.3

200

407

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

58.3

1053

6168

N19

ICPC

Speech disorder

6.6

57.8

153

236

F02.30

ICD-10 Finland

Dementia in Parkinson's disease without additional symptoms

+∞

57.4

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.5

57.3

499

2130

N05AX12

ATC

aripiprazole; systemic

6.0

56.7

163

280

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

56.2

916

5167

R1250

NOMESCO Finland

Evaluation of functional capability

4.9

56.1

190

396

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

4.4

56.0

215

509

N05AB03

ATC

perphenazine; systemic, rectal

3.7

54.9

250

691

N28

ICPC

Limited function/disability (N)

5.0

54.2

181

371

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

10.8

54.1

106

100

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.3

54.0

537

2451

P72

ICPC

Schizophrenia

6.5

53.8

145

229

N05BA06

ATC

lorazepam; systemic, sublingual

2.7

53.0

395

1545

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

52.4

1637

11287

N05AA01

ATC

chlorpromazine; systemic, rectal

6.5

52.4

140

219

D21

ICPC

Swallowing problem

5.5

51.9

160

300

N06AB04

ATC

citalopram; systemic

1.7

49.6

1122

7031

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.7

49.4

227

633

29580

ICD-8 Finland

Schizophrenia, Other

11.5

49.1

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.5

48.8

410

1712

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.4

47.4

246

755

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.3

47.1

493

2301

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.6

46.8

367

1475

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

8.4

45.3

102

124

G90.3

ICD-10 Finland

Multi-system degeneration

64.3

44.2

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.8

44.1

198

541

A04

ICPC

Weakness/tiredness general

1.9

44.0

744

4218

N05AN01

ATC

lithium; oral

4.7

43.7

154

335

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.0

42.8

594

3127

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

9.4

42.4

N04AA01

ATC

trihexyphenidyl; oral

56.0

42.4

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

40.9

422

1953

S01.0

ICD-10 Finland

Open wound of scalp

2.1

40.6

490

2433

U04

ICPC

Incontinence urine

2.5

40.3

340

1423

G23.8

ICD-10 Finland

Other specified degenerative diseases of basal ganglia

44.9

40.0

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.5

39.8

192

557

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

39.4

318

1298

F20.5

ICD-10 Finland

Residual schizophrenia

9.4

38.8

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

16.5

38.5

F02.32

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly hallucinations

379.9

38.1

R35

ICD-10 Finland

Polyuria

2.1

37.9

439

2139

Z2445

NOMESCO Finland

Psychologist

3.7

37.8

174

487

N03AX12

ATC

gabapentin; oral

1.7

37.7

806

4921

29530

ICD-8 Finland

Schizophrenia, Paranoid type

10.6

37.2

N99

ICPC

Neurological disease other

5.4

37.1

114

214

N30.0

ICD-10 Finland

Acute cystitis

1.8

36.7

750

4509

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

36.6

822

5091

R47.1

ICD-10 Finland

Dysarthria and anarthria

5.6

36.5

109

198

2959E

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]

18.2

36.1

R60.0

ICD-10 Finland

Localized oedema

1.8

35.4

682

4023

F20

ICD-10 Finland

Schizophrenia

11.3

35.3

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

11.3

34.9

188

Kela drug reimbursment

Psychosis requiring demanding treatment

7.0

33.9

123

AA5QN

NOMESCO Finland

93.1

33.7

S72.0

ICD-10 Finland

Fracture of neck of femur

2.3

33.4

328

1480

29570

ICD-8 Finland

Schizophrenia, Schizo-affective type

11.6

33.2

R13

ICD-10 Finland

Dysphagia

2.1

33.0

406

2027

K59.0

ICD-10 Finland

Constipation

2.1

32.5

380

1855

F20.0

ICD-10 Finland

Paranoid schizophrenia

10.1

32.5

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

7.1

32.3

114

N05BA01

ATC

diazepam; systemic, rectal

1.7

32.0

719

4436

P20

ICPC

Memory disturbance

1.6

31.7

873

5704

N04BC01

ATC

bromocriptine; oral

114.0

31.7

29510

ICD-8 Finland

Schizophrenia, Hebephrenic type

14.0

31.5

130

Kela drug reimbursment

Malignant tumour

0.4

31.5

133

3236

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.2

31.1

340

1613

2959C

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]

12.6

30.7

N04BX04

ATC

opicapone; oral

+∞

30.2

M48.0

ICD-10 Finland

Spinal stenosis

1.7

30.1

772

4944

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

3.6

29.4

138

394

N04BC07

ATC

apomorphine; parenteral

+∞

29.2

34200

ICD-8 Finland

Paralysis agitans, Parkinsonismus

+∞

29.2

W19

ICD-10 Finland

Unspecified fall

1.8

28.9

513

2935

M54.5

ICD-10 Finland

Low back pain

1.5

28.9

1408

10473

P29

ICPC

Psychological sympt/compl other

2.8

28.9

192

699

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.1

28.9

160

518

F20.10

ICD-10 Finland

Raise schizophrenia continuously

12.9

28.8

N08

ICPC

Abnormal involuntary movements

12.6

28.0

G04BD08

ATC

solifenacin; oral

1.9

27.7

436

2393

R41.0

ICD-10 Finland

Disorientation, unspecified

2.4

27.6

240

1018

F0230, G20

ICD-10 Finland

+∞

27.1

F0232, G20

ICD-10 Finland

+∞

27.1

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

32.0

26.8

N05CD07

ATC

temazepam; oral

1.6

26.5

802

5347

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.6

25.9

201

803

SPAT1254

SPAT

Administration of medicine

1.6

25.7

830

5620

L03

ICPC

Low back symptom/complaint

1.5

25.6

1056

7559

S06.0

ICD-10 Finland

Concussion

1.8

25.5

494

2904

R32

ICD-10 Finland

Unspecified urinary incontinence

2.7

25.5

181

689

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

25.4

419

2337

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.5

25.2

211

880

SPAT1053

SPAT

Memory test

1.5

25.1

1042

7468

SPAT1240

SPAT

Therapeutic discussion

2.0

24.8

336

1740

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

7.8

24.6

2953E

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]

12.3

24.5

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

24.4

1261

9437

N02BE01

ATC

paracetamol; systemic, rectal

1.4

24.2

4380

40332

N06AX21

ATC

duloxetine; oral

1.8

23.9

421

2396

R1260

NOMESCO Finland

Evaluation of communicative skills

3.1

23.8

134

440

N05AD01

ATC

haloperidol; systemic

2.4

23.5

206

881

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.4

23.5

116

346

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

23.5

412

2345

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.2

23.4

126

401

N06AX03

ATC

mianserin; oral

2.1

23.3

268

1299

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.7

23.3

103

281

R2110

NOMESCO Finland

Giving the first information

2.0

23.0

291

1468

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

7.6

22.7

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

22.2

516

3199

R55

ICD-10 Finland

Syncope and collapse

1.6

22.2

646

4254

K02.1

ICD-10 Finland

Caries of dentine

1.3

22.0

2163

17978

N04BX01

ATC

tolcapone; oral

+∞

21.9

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

21.9

271

1357

H02AB02

ATC

dexamethasone; systemic

0.5

21.6

164

3255

R42

ICD-10 Finland

Dizziness and giddiness

1.4

21.6

1179

8883

AAW01

NOMESCO Finland

Implantation of intracranial stimulation device

220.8

21.6

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.3

21.6

198

865

2957A

ICD-9 Finland

Schizophrenic psychoses, Schizo-affective type

9.6

21.2

N03AX09

ATC

lamotrigine; oral

2.7

21.2

150

569

N86

ICPC

Multiple sclerosis

7.9

21.1

N06AX16

ATC

venlafaxine; oral

1.7

21.0

460

2806

G04BD04

ATC

oxybutynin; oral, transdermal

1.9

20.7

337

1868

G23.2

ICD-10 Finland

Multiple system atrophy, parkinsonian type [MSA-P]

210.7

20.6

TAB00

NOMESCO Finland

Lumbar puncture

2.3

20.4

188

826

S70.0

ICD-10 Finland

Contusion of hip

2.2

20.2

220

1042

Z75.5

ICD-10 Finland

Holiday relief care

3.4

20.1

285

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.5

20.1

280

J01EA01

ATC

trimethoprim; systemic

1.4

20.0

1220

9357

SPAT1301

SPAT

No procedures

1.3

20.0

1631

13123

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.5

20.0

158

641

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.7

19.8

238

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

4.3

19.7

171

H50.52

ICD-10 Finland

Exophoria

5.5

19.4

104

G24.9

ICD-10 Finland

Dystonia, unspecified

8.5

19.3

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.2

19.2

100

313

29560

ICD-8 Finland

Residual schizophrenia

11.8

18.7

C01CA01

ATC

etilefrine; systemic

4.3

18.7

166

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

4.0

18.7

185

R23

ICPC

Voice symptom/complaint

3.1

18.6

103

336

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

18.6

486

3110

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

9.8

18.6

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

12.3

18.5

C03CA01

ATC

furosemide; systemic

1.3

18.4

1928

16048

P99

ICPC

Psychological disorders other

3.2

18.3

296

G04BD11

ATC

fesoterodine; oral

2.2

18.3

194

907

2959A

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]

8.7

18.3

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

18.3

350

2045

2951C

ICD-9 Finland

Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]

16.2

18.3

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.2

18.3

165

R44.1

ICD-10 Finland

Visual hallucinations

6.0

18.2

EBA00

NOMESCO Finland

Extraction of tooth

1.3

17.9

1345

10645

29500

ICD-8 Finland

Schizophrenia, Simple type

10.7

17.9

SPAT1244

SPAT

Occupational therapy

3.7

17.8

213

F06.0

ICD-10 Finland

Organic hallucinosis

9.5

17.8

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

18.1

17.7

F02.31

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly paranoidism

+∞

17.7

F02.34

ICD-10 Finland

Dementia in Parkinson's disease, other additional symptoms of mixed type

+∞

17.7

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

17.6

149

627

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.1

17.5

198

953

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

17.4

823

6008

XKD00

NOMESCO Finland

Uroflowmetry

1.4

17.3

1043

7956

F20.1

ICD-10 Finland

Hebephrenic schizophrenia

14.8

17.1

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

3.1

17.1

301

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

9.8

17.1

M03BX01

ATC

baclofen; systemic

3.1

17.0

302

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.3

16.7

1187

G04BD07

ATC

tolterodine; oral

1.8

16.6

303

1749

SPAT1235

SPAT

Mental health, emotional support

6.4

16.5

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.0

16.4

327

G04CA02

ATC

tamsulosin; oral

1.3

16.3

1548

12651

29540

ICD-8 Finland

Acute schizophrenia episode

12.1

16.3

2953C

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN]

11.2

16.2

J01CA08

ATC

pivmecillinam; oral

1.3

16.1

1503

12253

29999

ICD-8 Finland

Unspecified psychosis

6.3

16.0

IGY02

SPAT

9.0

15.9

A03FA01

ATC

metoclopramide; systemic, rectal

0.7

15.6

510

7144

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

6.5

15.6

SPAT1167

SPAT

Insertion of urinary catheter

1.9

15.5

228

1220

F05.9

ICD-10 Finland

Delirium, unspecified

2.4

15.5

135

578

F02.3

ICD-10 Finland

Dementia in Parkinson disease

160.4

15.5

N05AL01

ATC

sulpiride; systemic

3.0

15.4

306

D12

ICPC

Constipation

2.0

15.1

187

938

G04BD09

ATC

trospium; oral

2.2

15.0

158

741

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

5.4

14.9

H50.31

ICD-10 Finland

Intermittent exotropia

5.7

14.9

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

14.8

284

1664

SPAT1050

SPAT

Extensive neurological examination

2.4

14.8

127

539

SPAT1262

SPAT

Handing over of treatment supplies

1.4

14.7

935

7175

N87

ICD-10 Finland

Dysplasia of cervix uteri

80.3

14.6

L84

ICD-10 Finland

Corns and callosities

2.0

14.5

176

874

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

14.4

456

3053

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.5

14.4

112

451

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

4.4

14.4

116

RF120

NOMESCO Finland

3.4

14.3

200

M04AA01

ATC

allopurinol; systemic

0.7

14.3

426

6071

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

14.3

779

5822

F20.19

ICD-10 Finland

Hebefren schizophrenia UNS

14.4

14.0

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.3

14.0

962

Z29

ICPC

Social problem NOS

2.7

13.8

359

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

13.7

1435

11831

K08.3

ICD-10 Finland

Retained dental root

1.6

13.7

336

2113

I95.9

ICD-10 Finland

Hypotension, unspecified

2.5

13.7

102

405

Z02.4

ICD-10 Finland

Examination for driving licence

0.8

13.7

897

11300

F22.0

ICD-10 Finland

Delusional disorder

3.0

13.6

269

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

13.6

999

7837

K11.72

ICD-10 Finland

Xerostomia

14.7

13.5

F023, G20

ICD-10 Finland

+∞

13.5

F0234, G20

ICD-10 Finland

+∞

13.5

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

6.6

13.5

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

13.5

613

4427

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.3

13.4

124

547

R5110

SPAT

2.1

13.4

149

717

A29

ICPC

General symptom/complaint other

1.5

13.4

532

3747

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

13.3

276

1658

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.5

13.3

393

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

13.2

2013

17368

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.5

13.1

172

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.3

13.1

979

R33

ICD-10 Finland

Retention of urine

1.5

13.0

498

3477

F20.34

ICD-10 Finland

Undifferentiated schizophrenia with partial recurrence

10.9

13.0

M41.4

ICD-10 Finland

Neuromuscular scoliosis

50.1

12.8

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

12.8

198

1085

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.3

12.7

115

505

Z50.5

ICD-10 Finland

Speech therapy

3.2

12.7

209

UKC02

NOMESCO Finland

Cystoscopy

1.3

12.7

955

7506

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

12.6

416

2814

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

12.5

714

5371

L17

ICPC

Foot/toe symptom/complaint

1.3

12.5

1137

9188

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

12.4

183

985

S00.0

ICD-10 Finland

Superficial injury of scalp

2.3

12.4

112

491

G72.8

ICD-10 Finland

Other specified myopathies

2.5

12.3

407

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.6

12.2

302

1905

N05AD03

ATC

melperone; systemic

2.5

12.2

375

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

5.5

12.2

E86

ICD-10 Finland

Volume depletion

2.0

12.2

152

770

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.4

12.1

1105

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.9

12.1

170

898

F25.2

ICD-10 Finland

Schizoaffective disorder, mixed type

8.7

12.0

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.3

11.9

109

482

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

11.9

420

2881

M41.9

ICD-10 Finland

Scoliosis, unspecified

3.0

11.9

229

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.5

11.8

362

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

11.8

449

3134

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

11.8

1952

16941

SPAT1172

SPAT

Guidance concerning hydration

2.0

11.7

148

751

N05AE04

ATC

ziprasidone; systemic

9.6

11.7

G35

ICD-10 Finland

Multiple sclerosis

3.5

11.7

152

N06AB06

ATC

sertraline; oral

1.6

11.7

343

2258

N05AF01

ATC

flupentixol; systemic

2.6

11.7

316

F25

ICD-10 Finland

Schizoaffective disorders

11.1

11.5

AAG99

NOMESCO Finland

Other stereotactic intracranial operation

+∞

11.5

Z3226

NOMESCO Finland

Physiotherapist

1.3

11.4

830

6482

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

7.5

11.4

S22.3

ICD-10 Finland

Fracture of rib

1.6

11.3

305

1964

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

11.3

928

7379

AA400

NOMESCO Finland

Electroconvulsive therapy

4.2

11.3

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

11.3

141

715

S01.8

ICD-10 Finland

Open wound of other parts of head

2.7

11.3

269

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.0

11.2

140

707

N05AX13

ATC

paliperidone; systemic

10.5

11.2

G25.1

ICD-10 Finland

Drug-induced tremor

7.2

11.2

SPAT1263

SPAT

Sampling

1.2

11.2

1916

16663

EBA30

NOMESCO Finland

Excision of root of tooth

1.7

11.2

249

1527

M79.6

ICD-10 Finland

Pain in limb

1.2

11.1

1507

12768

U07

ICPC

Urine symptom/complaint other

1.6

11.1

276

1744

R4110

SPAT

2.0

11.0

136

684

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.7

11.0

271

WYA20

NOMESCO Finland

Home visit

2.3

11.0

100

443

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

10.9

485

3483

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

10.9

2360

21005

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

3.9

10.9

110

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

4.2

10.9

F20.8

ICD-10 Finland

Other schizophrenia

6.2

10.9

AA1AA

NOMESCO Finland

Head X-ray examination

3.0

10.9

200

WX290

NOMESCO Finland

Other blockade of nerve

1.3

10.9

1359

11399

N03AF02

ATC

oxcarbazepine; oral

2.0

10.9

129

642

RF420

NOMESCO Finland

2.8

10.8

245

F20.01

ICD-10 Finland

Paranoid schizophrenia periodically with gradual deterioration

10.6

10.7

Z50.1

ICD-10 Finland

Other physical therapy

1.6

10.7

258

1617

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

3.1

10.6

181

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

3.8

10.6

113

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.4

10.6

443

3148

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

4.6

10.6

H02AB06

ATC

prednisolone; systemic

0.8

10.4

1693

19360

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

10.4

728

5646

N05AB02

ATC

fluphenazine; systemic

3.6

10.4

130

SPAT1101

SPAT

Orthostatic test

1.6

10.4

257

1622

IGY99

SPAT

7.7

10.4

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

3.0

10.3

191

ICB03

SPAT

10.6

10.3

N04AB02

ATC

orphenadrine (chloride); systemic

18.8

10.2

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

4.5

10.2

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

10.1

601

4551

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.5

10.1

325

N06DA02

ATC

donepezil; oral

1.5

10.0

336

2281

W06

ICD-10 Finland

Fall involving bed

3.1

10.0

178

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.1

10.0

173

P03

ICPC

Feeling depressed

1.7

9.9

205

1231

R63.4

ICD-10 Finland

Abnormal weight loss

1.8

9.9

173

985

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

9.9

103

484

WF002

NOMESCO Finland

Radical radiotherapy

0.5

9.9

1771

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.6

9.9

254

1615

SPAT1243

SPAT

Psychiatric/psychological examination

2.7

9.8

238

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.3

9.8

720

5626

S20.2

ICD-10 Finland

Contusion of thorax

1.7

9.8

204

1231

F25.0

ICD-10 Finland

Schizoaffective disorder, manic type

8.1

9.8

97010

ICD-8 Finland

Adverse effect of psychotherapeutics, Tranquillisers

5.2

9.8

A08

ICPC

Swelling

1.7

9.8

205

1238

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

10.6

9.8

2956C

ICD-9 Finland

Schizophrenic psychoses, Residual schizophrenia[RESIDUAALINEN SKITSOFRENIA,KROONINEN]

9.5

9.7

N02CA01

ATC

dihydroergotamine; nasal, systemic

4.8

9.7

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.6

9.7

118

P98

ICPC

Psychosis NOS/other

5.8

9.6

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

9.6

159

891

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

9.6

422

3025

XKC03

NOMESCO Finland

Water cystometry

1.8

9.6

150

828

N05AE03

ATC

sertindole; oral

15.0

9.5

N05CF01

ATC

zopiclone; oral

1.2

9.5

1592

13762

F03

ICD-10 Finland

Unspecified dementia

1.6

9.4

270

1771

P01

ICPC

Feeling anxious/nervous/tense

1.7

9.4

193

1162

N06AX26

ATC

vortioxetine; oral

1.8

9.4

150

836

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.0

9.3

171

Z11

ICPC

Compliance/being ill problem

3.3

9.3

133

WX110

NOMESCO Finland

Local anesthesy

1.2

9.3

2807

25642

29630

ICD-8 Finland

Affective psychoses, Manic-depressive psychosis, circular type

9.5

9.2

29520

ICD-8 Finland

Schizophrenia, Catatonic type

9.5

9.2

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.4

9.2

301

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

7.3

9.2

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

9.2

163

939

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

5.4

9.2

K07

ICPC

Swollen ankles/oedema

1.6

9.1

229

1453

A06AX04

ATC

linaclotide; oral

6.2

9.1

L01BC06

ATC

capecitabine; oral

0.4

9.0

967

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

9.0

278

1854

3339X

ICD-9 Finland

Other extrapyramidal disease and abnormal movement disorders, Other and unspecified extrapyramidal diseases and abnormal movement disorders

36.7

9.0

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

3.5

9.0

115

SPAT1252

SPAT

Overall medication plan or its review

1.4

9.0

361

2548

SPAT1304

SPAT

Counselling and guidance related to ageing

1.4

8.9

403

2907

G21.2

ICD-10 Finland

Secondary parkinsonism due to other external agents

24.0

8.9

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.5

8.9

111

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

8.9

632

4918

U05

ICPC

Urination problems other

1.6

8.9

238

1538

Y94.0

ICD-10 Finland

Accident at home

2.1

8.8

455

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

2.1

8.8

443

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.8

8.8

149

846

N03AF01

ATC

carbamazepine; oral, rectal

1.6

8.8

242

1570

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.4

8.8

958

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.5

8.8

254

2962E

ICD-9 Finland

Affective psychoses, Major depressive disorder, single episode[PSYCH.BIPOLARIS MANICA,VAIKEA-ASTE,PSYKOOT PIIRTEIT]

8.6

8.8

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.8

8.8

135

743

F20.08

ICD-10 Finland

Paranoid schizophrenia other definite

9.5

8.8

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

8.7

173

1029

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.9

8.7

121

642

L29

ICPC

Musculoskeletal sympt/complt other

1.5

8.7

304

2084

N03AA03

ATC

primidone; oral

5.6

8.7

SPAT1260

SPAT

Consultation of another employee

1.3

8.7

793

6378

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.8

8.7

200

G21

ICD-10 Finland

Secondary parkinsonism

50.0

8.7

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.3

8.6

344

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

4.5

8.6

Z60.8

ICD-10 Finland

Other problems related to social environment

5.0

8.6

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.0

8.6

101

504

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.1

8.6

482

R25.8

ICD-10 Finland

Other and unspecified abnormal involuntary movements

5.8

8.6

RF433

NOMESCO Finland

11.6

8.6

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

3.1

8.5

142

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

4.4

8.5

A01

ICPC

Pain general/multiple sites

1.5

8.5

314

2177

R44.3

ICD-10 Finland

Hallucinations, unspecified

3.5

8.5

105

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

8.5

285

1938

N04AC01

ATC

benzatropine; systemic

27.5

8.5

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

6.0

8.4

K56.2

ICD-10 Finland

Volvulus

3.1

8.4

138

G22

ICD-10 Finland

Parkinsonism in diseases classified elsewhere

90.2

8.4

G23.3

ICD-10 Finland

Multiple system atrophy, cerebellar type [MSA-C]

90.2

8.4

S20

ICPC

Corn/callosity

2.0

8.4

101

508

2956E

ICD-9 Finland

Schizophrenic psychoses, Residual schizophrenia[RESIDUAALINEN SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]

12.8

8.4

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

8.3

842

6859

K02

ICD-10 Finland

Dental caries

1.6

8.3

235

1536

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

8.3

1388

11960

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.8

8.3

185

R30.1

ICD-10 Finland

Vesical tenesmus

2.1

8.3

429

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

7.1

8.2

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

7.1

8.2

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.4

8.2

291

C10AA07

ATC

rosuvastatin; oral

0.8

8.2

789

9557

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.6

8.2

181

1111

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

8.2

2021

18062

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

2.1

8.2

401

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.0

8.2

147

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.5

8.1

253

1693

359

Kela drug reimbursment

Mirabegroni

2.9

8.1

162

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.5

8.1

1450

29820

ICD-8 Finland

Other psychoses, Reactive confusion

7.5

8.1

N17

ICPC

Vertigo/dizziness

1.3

8.1

509

3883

SPAT1360

SPAT

Extensive global examination

1.4

8.1

355

2549

30180

ICD-8 Finland

Personality disorders, Immatura

4.3

8.1

31099

ICD-8 Finland

Borderline mental retardation, Other and unspecified

8.1

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

2.9

8.1

164

H53.2

ICD-10 Finland

Diplopia

1.8

8.1

131

736

M43.1

ICD-10 Finland

Spondylolisthesis

1.7

8.0

149

871

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

8.0

419

3101

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.4

8.0

372

2697

G24.3

ICD-10 Finland

Spasmodic torticollis

3.2

8.0

121

R39.1

ICD-10 Finland

Other difficulties with micturition

1.7

8.0

147

856

B03BA03

ATC

hydroxocobalamin; parenteral

1.4

8.0

315

2211

G25

ICD-10 Finland

Other extrapyramidal and movement disorders

8.9

8.0

A04AA02

ATC

granisetron; systemic, transdermal

0.6

8.0

1693

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

3.8

8.0

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

8.0

1272

10905

N05BA12

ATC

alprazolam; oral

1.4

8.0

387

2832

N03AX16

ATC

pregabalin; oral

1.2

7.9

995

8310

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

1.9

7.9

116

627

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.7

7.9

144

835

R26

ICD-10 Finland

Abnormalities of gait and mobility

4.7

7.9

IHZ05

SPAT

3.6

7.9

RF410

NOMESCO Finland

2.6

7.9

214

ZYC01

SPAT

1.7

7.9

168

1023

SPAT1125

SPAT

Stoma care and guidance

2.1

7.9

430

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.4

7.8

467

3535

K88

ICPC

Postural hypotension

2.6

7.8

208

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.3

7.8

568

4426

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

7.8

1147

9748

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.2

7.8

119

L76

ICPC

Fracture: other

1.8

7.8

126

706

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.7

7.7

346

4624

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.6

7.7

191

1211

3321A

ICD-9 Finland

Parkinson's disease, Secondary Parkinsonism

45.0

7.7

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.5

7.7

229

2951E

ICD-9 Finland

Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]

15.0

7.7

SPAT1251

SPAT

Organisation of medication

1.6

7.7

189

1197

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.5

7.7

217

1420

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.4

7.6

761

IFA99

SPAT

18.4

7.6

AA052

NOMESCO Finland

18.4

7.6

L75

ICPC

Fracture: femur

2.1

7.5

356

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.2

7.5

311

H51.1

ICD-10 Finland

Convergence insufficiency and excess

8.8

7.5

R27.0

ICD-10 Finland

Ataxia, unspecified

3.9

7.5

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

7.5

182

1150

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

7.4

1344

11649

TJD20

NOMESCO Finland

Change of gastrostomy tube

3.8

7.4

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

7.4

2666

24512

IBB01

SPAT

80.2

7.4

S72.1

ICD-10 Finland

Pertrochanteric fracture

1.8

7.4

127

727

L03AA02

ATC

filgrastim; parenteral

0.4

7.4

702

F31

ICD-10 Finland

Bipolar affective disorder

3.2

7.4

113

S01

ICD-10 Finland

Open wound of head

2.4

7.4

260

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.3

7.3

443

M54

ICD-10 Finland

Dorsalgia

1.4

7.3

376

2778

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

7.3

1417

12362

N04C02

ATC

+∞

7.3

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.3

7.2

552

4335

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

6.2

7.2

M40.1

ICD-10 Finland

Other secondary kyphosis

6.2

7.2

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.0

7.2

399

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.3

7.2

678

5474

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.1

7.2

352

N05BE01

ATC

buspirone; oral

1.9

7.2

100

534

TKC22

NOMESCO Finland

Catheterisation instruction

1.8

7.2

114

638

N02AA05

ATC

oxycodone; systemic

1.3

7.1

751

6146

F2090

ICD-10 Finland

30.0

7.1

N05AC04

ATC

pipotiazine; systemic

30.0

7.1

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

0.5

7.1

926

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

7.1

325

2352

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.9

7.1

484

K03.66

ICD-10 Finland

Tooth plaque

1.5

7.1

233

1582

C10AX09

ATC

ezetimibe; oral

0.7

7.1

288

3905

2954A

ICD-9 Finland

Schizophrenic psychoses, Acute schizophrenic episode

5.6

7.0

NFB10

NOMESCO Finland

Primary partial prosthetic replacement of hip joint not using cement, other or unspecified

3.7

7.0

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

7.0

1489

13089

SPAT1104

SPAT

Monitoring of emergency patient

1.4

7.0

305

2189

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

4.9

6.9

H02.3

ICD-10 Finland

Blepharochalasis

1.4

6.9

267

1871

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.9

6.9

139

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.7

6.9

130

767

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

0.3

6.9

516

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

5.8

6.9

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

6.9

104

573

EBA10

NOMESCO Finland

Surgical removal of tooth

1.4

6.9

293

2093

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

6.9

1300

11303

AXX01

NOMESCO Finland

Memory assessment

13.8

6.9

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

6.9

704

5741

P70

ICPC

Dementia

1.8

6.9

113

639

IHZ07

SPAT

5.0

6.8

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.5

6.8

190

R74

ICPC

Upper respiratory infection acute

0.8

6.8

475

5975

L02

ICPC

Back symptom/complaint

1.4

6.8

283

2018

A03FA02

ATC

cisapride; oral, rectal

1.4

6.7

369

2754

N06AG02

ATC

moclobemide; oral

1.6

6.7

176

1135

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

6.7

670

5443

J01MA02

ATC

ciprofloxacin; systemic

1.2

6.7

1899

17086

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

3.3

6.7

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.6

6.7

156

974

M41.5

ICD-10 Finland

Other secondary scoliosis

4.7

6.7

K90

ICPC

Stroke/cerebrovascular accident

1.6

6.7

151

936

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

0.6

6.7

1502

R41.3

ICD-10 Finland

Other amnesia

1.6

6.6

149

922

F05.8

ICD-10 Finland

Other delirium

2.6

6.6

169

Z73.6

ICD-10 Finland

Limitation of activities due to disability

2.5

6.6

194

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

2.9

6.6

123

SPAT1139

SPAT

Nutrition survey

1.6

6.6

142

872

D07AA02

ATC

hydrocortisone; topical

1.3

6.6

459

3557

A04AA55

ATC

palonosetron, combinations; systemic

0.3

6.6

467

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.6

6.5

140

858

P73

ICPC

Affective psychosis

4.8

6.5

N06AB03

ATC

fluoxetine; oral

1.3

6.5

430

3306

ZYC02

SPAT

6.8

6.5

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

6.5

167

1075

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.3

6.5

481

3765

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

1.9

6.5

496

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.4

6.4

202

G24.8

ICD-10 Finland

Other dystonia

4.2

6.4

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

0.6

6.4

107

1712

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.5

6.4

195

1304

U02

ICPC

Urinary frequency/urgency

1.3

6.4

513

4058

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

4.0

6.4

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

3.5

6.4

L86

ICPC

Back syndrome with radiating pain

1.5

6.4

211

1439

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.9

6.3

121

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

0.7

6.3

306

4044

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

6.3

316

2328

30088

ICD-8 Finland

Neuroses, Other

3.4

6.3

207

Kela drug reimbursment

Chronic arrhythmias

0.8

6.3

586

7139

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

2.4

6.3

216

F20.29

ICD-10 Finland

Catat schizophrenia UNS

18.0

6.3

F02.33

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly depression

+∞

6.2

NF1AA

NOMESCO Finland

Hip X-ray examination

1.3

6.2

409

3143

RF432

NOMESCO Finland

26.7

6.2

RF214

NOMESCO Finland

7.0

6.2

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.5

6.2

206

1404

R11

ICD-10 Finland

Nausea and vomiting

1.4

6.2

310

2284

ZXY02

NOMESCO Finland

Neuropsychologist

3.9

6.2

RF210

NOMESCO Finland

1.8

6.2

105

604

2962C

ICD-9 Finland

Affective psychoses, Major depressive disorder, single episode[PSYCHOSIS BIPOLARIS MANICA,KESKIVAIKEA]

7.7

6.1

F21

ICPC

2.3

6.1

214

30099

ICD-8 Finland

Neuroses, Unspecified neurosis

4.6

6.1

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.2

6.1

NOMESCO Finland

Guidance supporting rehabilitation

12.5

6.1

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.9

6.1

443

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

6.1

2039

18557

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.5

6.0

176

1166

N05AE02

ATC

molindone; oral

10.0

6.0

29620

ICD-8 Finland

Affective psychoses, Manic depressive psychosis, depressed type

6.7

6.0

183

Kela drug reimbursment

Lamotrigin and topiramate

3.0

6.0

103

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3026008) Bacteria identified in Urine by Culture

2494

17314

1.73

90.93

4.3

3.5

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

101

121

8.47

77.97

1.9

1.2

nmol/l

124.7

133.1

0.15

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2342

17180

1.58

61.76

2.5

2.2

u/l

239.2

216.2

0.53

2197

15961

(3019309) Folate [Moles/volume] in Red Blood Cells

1798

12383

1.64

61.67

1.9

1.8

nmol/l

1197.0

1167.6

0.65

1383

9167

(3009466) Valproate [Moles/volume] in Serum or Plasma

207

617

3.44

57.19

6.1

4.0

umol/l

370.7

342.5

1.80

188

516

(3031040) Bacteria [#/volume] in Urine by Automated count

4093

34532

1.54

53.91

6.6

5.0

e6/l

1905.9

2102.5

0.06

588

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2978

23672

1.49

50.91

2.3

2.1

pmol/l

88.2

92.9

7.57

1775

12347

(3021960) Folate [Moles/volume] in Serum or Plasma

1894

14048

1.50

43.61

1.7

1.6

nmol/l

18.6

20.1

4.34

1657

11844

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3375

28048

1.44

42.63

5.6

6.9

mmol/l

1.2

1.70

2849

23461

(3023368) Bacteria identified in Blood by Culture

2182

16811

1.46

40.81

4.2

4.4

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

115

6.14

40.75

12.5

11.3

mmol/l

0.7

0.6

1.13

108

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1686

12389

1.49

39.93

1.8

1.7

pmol/l

12760271.3

26377036.7

0.73

1395

9952

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1389

9955

1.51

36.62

2.0

1.9

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3070

25506

1.40

36.27

5.2

6.1

mmol/l

1.2

0.14

2753

22863

(3035350) Ketones [Presence] in Urine by Test strip

2932

24376

1.38

33.41

5.1

4.0

estimate

0.0

0.50

536

4539

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1009

6880

1.56

33.12

1.9

1.8

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

106

5.71

32.47

2.4

2.5

nmol/l

158.5

139.8

0.52

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

246

1085

2.32

32.38

1.4

1.2

mg/l

472.9

595.7

3.77

231

1015

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

220

926

2.43

32.18

1.4

1.3

e6/l

4.0

26.6

2.33

181

716

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1000

6851

1.55

32.03

1.9

1.8

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

219

927

2.41

31.64

1.4

e6/l

284.7

1087.9

2.70

192

761

(3018418) pH of Serum or Plasma

2090

16565

1.39

31.14

3.2

4.1

7.4

1.82

359

3170

(3009261) Glucose [Presence] in Urine by Test strip

2946

24716

1.36

30.71

5.2

4.1

estimate

0.0

1.34

542

4445

(3021601) Nitrite [Presence] in Urine by Test strip

2909

24404

1.36

30.10

6.8

5.3

estimate

0.0

0.00

545

4572

(3037467) Urinalysis macro (dipstick) panel - Urine

3979

35088

1.37

29.66

5.6

4.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2295

18637

1.37

28.85

5.6

4.4

—

(3019150) Specific gravity of Urine by Refractometry

1464

11033

1.43

28.71

5.5

4.5

kg/l

1.0

1.07

235

1762

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

576

3539

1.69

28.70

1.5

—

(3030467) Casts [#/volume] in Urine by Automated count

1956

15743

1.35

25.14

3.7

3.4

e6/l

0.4

0.5

1.28

1538

12083

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2623

22095

1.32

24.54

4.7

4.2

ng/l

61.8

86.2

0.44

2105

17221

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

112

387

2.93

24.31

1.0

ng/l

259.4

330.3

2.53

254

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

112

388

2.92

24.20

1.0

ng/l

34.4

45.4

2.89

252

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

112

389

2.91

24.09

1.0

ng/l

635.3

690.1

0.67

249

(3044290) Cell count panel - Cerebral spinal fluid

190

856

2.26

23.84

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

205

953

2.19

23.83

1.3

1.2

mmol/l

3.9

0.07

191

884

(3018095) Leukocytes [#/volume] in Urine

2329

19349

1.33

23.79

4.4

4.0

e6/l

145.8

115.9

0.65

1766

14301

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3923

35054

1.32

23.56

3.9

pmol/l

15.4

15.1

10.90

3493

30988

(3002582) Erythrocytes [#/volume] in Urine

2100

17212

1.33

23.50

3.9

3.5

e6/l

92.0

105.8

0.16

1669

13464

(36304419) Bacteria [Presence] in Urine

1861

15021

1.34

23.01

3.7

3.4

—

(3029937) Albumin [Presence] in Urine by Test strip

1706

13634

1.35

22.43

5.6

4.4

estimate

0.0

0.88

515

4318

(3024561) Albumin [Mass/volume] in Serum or Plasma

2813

24266

1.29

20.81

3.9

4.9

g/l

34.6

34.5

0.34

2580

22312

(3011397) Hemoglobin [Presence] in Urine by Test strip

1507

11937

1.35

20.73

4.8

3.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3571

31774

1.29

20.66

5.0

4.9

mmol/l

6.7

6.9

5.07

3400

29931

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

566

3786

1.54

19.66

1.9

1.7

—

(3000850) Epithelial cells [#/volume] in Urine

1531

12253

1.33

19.42

2.9

2.7

e6/l

4.9

4.5

0.68

1341

10729

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1800

14738

1.31

19.41

2.3

mg/l

3.0

3.1

1.02

1493

12447

(3008152) Bicarbonate [Moles/volume] in Arterial blood

586

3984

1.52

18.87

5.9

6.8

mmol/l

25.7

24.5

13.21

545

3724

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1236

9696

1.34

17.74

3.2

3.0

e6/l

1.3

1.2

0.51

750

5745

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

275

2.90

17.04

1.1

nmol/l

1.3

13.1

1.56

(3026782) Osmolality of Urine

1426

11476

1.31

17.04

3.3

2.9

mosm/kgh2o

562.2

553.0

0.88

1222

9761

(3015377) Calcium [Moles/volume] in Serum or Plasma

2174

18667

1.25

15.09

2.4

3.4

mmol/l

2.3

2.4

1.94

1839

15888

(3023410) Appearance of Cerebral spinal fluid

385

2.46

14.79

1.4

—

(3019060) Gas panel - Arterial blood

594

4255

1.44

14.59

4.1

4.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2531

22161

1.24

14.58

2.5

2.3

—

(4034850)

266

1613

1.68

13.88

11.5

11.9

—

(3014271) Vancomycin [Susceptibility]

385

2.41

13.84

3.9

2.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4608

43149

1.26

13.81

5.1

4.7

mu/l

1.9

2.1

2.96

4156

38348

(3016018) Differential panel - Cerebral spinal fluid

424

2.33

13.69

1.2

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1325

10828

1.28

13.66

2.6

3.2

mmol/l

2.4

2.5

4.90

1140

9413

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2328

20307

1.23

13.59

2.2

nmol/l

77.1

79.4

3.37

1999

17651

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

305

2.58

13.55

1.0

mg/l

273.3

285.4

0.86

266

(3003396) Base excess in Arterial blood by calculation

919

7175

1.33

13.26

5.0

6.7

mmol/l

1.7

1.1

5.35

755

5534

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

310

2.54

13.12

2.7

2.3

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

919

7203

1.32

12.88

5.1

6.7

kpa

5.2

5.1

3.53

871

6834

(3027801) Oxygen [Partial pressure] in Arterial blood

918

7202

1.32

12.77

5.1

6.7

kpa

11.6

11.9

0.98

867

6826

(40761535) Cells panel - Urine sediment

651

4854

1.38

12.65

3.8

3.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1123

9082

1.29

12.44

3.5

3.2

e6/l

2.5

2.0

1.05

635

5170

(40768804) Tissue Pathology biopsy report

1710

19875

0.81

12.24

2.1

2.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

440

2.22

12.17

1.3

1.4

—

(4035726)

324

4788

0.66

11.88

1.3

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

291

1895

1.56

11.40

3.5

4.2

mmol/l

3.8

3.9

2.34

275

1766

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2235

19680

1.21

11.28

2.7

2.9

ug/l

145.1

162.8

3.12

1991

17722

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

239

2.61

11.16

1.1

1.4

—

(3016502) Oxygen saturation in Arterial blood

821

6484

1.31

10.78

5.2

6.9

95.0

95.3

0.72

783

6230

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1065

12866

0.79

10.50

1.5

1.6

mmol/l

1.2

1.3

6.78

862

10552

(3018405) Lactate [Moles/volume] in Arterial blood

329

2247

1.49

10.35

3.4

3.9

mmol/l

1.2

1.4

5.77

321

2211

(3002173) Hemoglobin [Mass/volume] in Arterial blood

746

5856

1.31

10.22

5.6

7.4

g/l

121.7

119.9

1.52

713

5651

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.28

10.10

2.3

1.7

umol/l

15.4

17.2

0.37

(3041096) Erythrocytes [Presence] in Urine by Automated

1466

12505

1.23

9.93

5.0

3.8

—

(1761868) Lipid panel - Serum or Plasma

1096

13099

0.80

9.70

3.3

3.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4322

45520

0.83

9.34

4.3

4.8

mmol/l

1.4

0.17

3838

40711

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

399

2884

1.41

9.31

4.5

4.1

48.1

47.3

0.25

391

2846

(3012516) Albumin [Mass/volume] in Urine

1503

17323

0.83

9.23

2.9

3.3

mg/l

297.7

331.9

0.12

991

11101

(3024354) Oxygen [Partial pressure] in Venous blood

610

4737

1.32

9.01

3.1

kpa

4.5

0.02

586

4554

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4173

44037

0.84

8.96

3.9

4.3

mmol/l

1.2

1.3

13.72

3666

38983

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

388

2811

1.41

8.94

2.7

2.6

0.7

1.50

366

2698

(3013707) Erythrocyte sedimentation rate by Westergren method

3899

36509

1.18

8.90

3.9

4.3

mm/h

12.9

14.5

8.41

3571

33221

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

364

2611

1.42

8.88

4.8

5.0

1.5

1.6

0.76

344

2453

(3020891) Body temperature

349

2492

1.42

8.74

4.5

4.7

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

354

2.13

8.65

1.2

mmol/l

1.9

2.2

2.18

334

(3009508) Creatinine [Moles/volume] in Urine

1532

17530

0.83

8.56

2.9

3.2

mmol/l

7.3

0.09

1241

14347

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

304

2132

1.45

8.41

1.9

2.2

ug/l

1166.9

689.2

0.25

278

2021

(3020682) Albumin/Creatinine [Ratio] in Urine

1610

18317

0.84

8.40

3.7

4.0

mg/mmol

6.8

9.9

4.00

1046

11600

(3007930) Methemoglobin/Hemoglobin.total in Blood

356

2578

1.40

8.25

4.9

5.0

0.9

0.28

338

2424

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1239

10568

1.22

8.20

1.7

mg/l

1.4

1.5

0.50

991

8254

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4385

45963

0.84

8.12

4.3

4.8

mmol/l

4.3

4.4

8.06

3927

41433

(3027273) Bicarbonate [Moles/volume] in Venous blood

416

3112

1.36

7.92

3.6

3.4

mmol/l

25.5

25.1

1.79

394

3018

(3022621) pH of Urine by Test strip

467

3574

1.33

7.65

4.2

3.3

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

7.34

7.55

4.0

6.7

—

(3019198) Lymphocytes [#/volume] in Blood

2733

25074

1.16

7.50

5.8

5.7

e9/l

1.8

1.9

0.20

2346

21611

(3004119) Hemoglobin [Mass/volume] in Venous blood

484

3752

1.31

7.25

3.3

3.2

g/l

126.9

127.3

0.16

470

3660

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1873

16729

1.17

7.22

2.4

2.6

u/l

55.3

58.9

2.95

1726

15357

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

120

1976

0.60

7.19

1.9

—

(3001604) Monocytes [#/volume] in Blood

2670

24516

1.16

7.12

5.5

5.6

e9/l

0.6

14.95

2262

20777

(3006315) Basophils [#/volume] in Blood

2685

24677

1.15

7.04

5.6

e9/l

0.0

17.09

2270

20942

(3036481) Cortisol [Moles/volume] in Serum or Plasma

531

4188

1.29

7.00

1.8

2.3

nmol/l

388.8

375.3

0.83

469

3821

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

229

2.24

6.74

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

518

6491

0.78

6.71

2.7

4.0

ug/l

10.8

25.6

1.56

416

5401

(3014576) Chloride [Moles/volume] in Serum or Plasma

902

7598

1.22

6.68

5.1

6.6

mmol/l

104.6

104.4

0.69

877

7420

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1070

9174

1.20

6.58

2.3

3.1

mmol/l

0.8

4.96

969

8482

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2109

19126

1.16

6.50

2.9

3.2

ng/l

1362.1

1838.0

7.15

1819

16674

(3021447) Carbon dioxide [Partial pressure] in Venous blood

700

5773

1.24

6.34

3.4

3.7

kpa

5.8

0.00

671

5582

(3027945) Reticulocytes/100 erythrocytes in Blood

880

7435

1.21

6.30

2.0

2.4

1.6

1.8

4.79

756

6495

(3047181) Lactate [Moles/volume] in Blood

260

1874

1.40

6.26

5.5

6.1

mmol/l

1.1

1.3

5.82

234

1668

(3023183) Ammonium ion [Moles/volume] in Plasma

177

1186

1.51

6.25

1.7

2.6

umol/l

26.6

34.7

5.51

139

979

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

194

1325

1.48

6.24

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

194

1325

1.48

6.24

1.4

1.3

—

(3000492) Spirometry study

286

3851

0.73

6.24

1.5

1.6

—

(3013115) Eosinophils [#/volume] in Blood

2744

25430

1.14

6.06

6.1

5.7

e9/l

0.2

7.82

2367

21871

(3026493) Urate [Moles/volume] in Serum or Plasma

1260

14310

0.85

6.05

2.4

2.9

umol/l

7695.0

6031.6

0.52

1032

12074

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4557

47296

0.86

5.92

4.9

5.5

mmol/l

2.5

2.6

9.05

4050

42424

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4938

47686

1.17

5.85

20.6

17.7

mg/l

27.9

27.4

0.47

4245

39186

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

102

616

1.67

5.64

1.5

—

(3002032) Base excess in Venous blood by calculation

690

5754

1.22

5.62

3.4

3.7

mmol/l

2.5

1.9

4.46

567

4634

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

553

6721

0.81

5.48

1.2

u/ml

7.2

14.4

2.65

205

2319

(3004588) Protein electrophoresis panel - Serum or Plasma

546

4457

1.25

5.44

1.9

2.4

—

(21494755) Public health laboratory ask at order entry panel

1446

0.60

5.33

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

526

4293

1.25

5.25

1.7

1.6

—

(3039000) Anion gap in Blood

192

1358

1.43

5.21

6.0

6.9

mmol/l

10.3

11.3

3.08

174

1221

(3018572) Chloride [Moles/volume] in Blood

192

1358

1.43

5.21

6.0

6.9

mmol/l

105.4

105.1

0.50

174

1221

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.05

5.21

2.3

2.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.05

5.21

2.3

2.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4140

39602

1.14

5.17

6.0

7.8

u/l

79.6

81.0

0.98

3851

37015

(3017143) Hepatitis C virus Ab [Presence] in Serum

291

3784

0.76

5.04

1.4

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

359

4535

0.78

4.98

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

239

2.02

4.98

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1276

11343

1.16

4.96

4.2

ng/l

143.5

460.4

3.50

1084

9838

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

304

3920

0.76

4.95

1.3

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

460

5640

0.80

4.95

1.3

titre

479.6

509.6

0.16

1250

(3020630) Protein [Mass/volume] in Serum or Plasma

639

5358

1.21

4.94

1.9

2.5

g/l

65.9

66.0

0.05

547

4783

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

411

1.76

4.93

1.1

—

3.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

737

6266

1.20

4.92

1.9

1.8

—

(3012544) pH of Venous blood

706

5981

1.20

4.90

3.4

3.7

7.4

—

(3028707) Methadone [Presence] in Urine by Screen method

143

2.31

4.83

1.5

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

256

1.96

4.81

1.2

1.1

mg/l

270.9

313.3

0.72

218

(40768800) Prostate Pathology biopsy report

105

1610

0.65

4.75

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

129

864

1.50

4.67

2.7

2.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1219

0.60

4.58

1.5

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

470

3851

1.24

4.56

5.7

8.3

0.7

2.98

465

3819

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

471

3865

1.24

4.51

5.6

8.2

1.4

1.3

0.51

465

3837

(3041354) Potassium [Moles/volume] in Venous blood

130

880

1.49

4.49

2.7

2.4

mmol/l

4.1

0.14

130

869

(3035285) Chloride [Moles/volume] in Venous blood

130

880

1.49

4.49

2.7

2.4

mmol/l

106.1

105.7

0.43

130

869

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

248

1879

1.33

4.47

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

272

1.88

4.38

1.3

1.1

mg/l

43.6

46.4

0.13

229

(3032080) INR in Blood by Coagulation assay

2599

24337

1.12

4.33

10.4

11.2

inr

1.3

1.4

2.80

732

6614

(3013650) Neutrophils [#/volume] in Blood by Automated count

3034

28669

1.11

4.26

8.5

8.8

e9/l

4.4

4.3

0.92

2602

24769

(3014111) Lactate [Moles/volume] in Serum or Plasma

621

5269

1.20

4.25

4.6

6.4

mmol/l

1.4

0.22

595

5037

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

355

2850

1.26

4.15

2.3

2.4

au/ml

33.2

25.2

—

(3022096) Basophils/100 leukocytes in Blood

2407

22508

1.11

4.03

5.6

5.9

0.6

0.7

9.06

2199

20768

(4010399)

292

3675

0.78

3.98

1.4

—

(4281824)

492

0.42

3.97

1.3

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

333

1.75

3.97

1.2

1.1

—

(40768793) Breast Pathology biopsy report

888

0.57

3.97

1.3

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

159

2173

0.72

3.93

2.4

3.3

u/ml

1593.7

2910.3

0.33

132

1856

(4198724)

3.13

3.92

1.5

1.4

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

184

2.02

3.92

1.4

1.3

63.2

59.2

0.22

156

(3022145) Colonoscopy Study observation

471

5597

0.83

3.75

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

318

2564

1.25

3.62

1.3

au/ml

81.1

60.1

0.58

113

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

693

6022

1.17

3.61

4.7

3.8

—

(3003181) Sodium [Moles/volume] in Urine

148

1077

1.38

3.54

1.3

mmol/l

72.2

62.2

2.24

115

874

(3006504) Eosinophils/100 leukocytes in Blood

2458

23127

1.10

3.52

5.5

5.9

2.6

2.9

5.50

2246

21315

(3024891) Influenza virus A+B Ag [Presence] in Specimen

149

1088

1.38

3.49

1.3

1.2

—

(40758558) Short blood count panel - Blood

1381

12619

1.12

3.41

6.4

6.7

—

(3045414) Leukocytes [Presence] in Urine

286

2295

1.26

3.41

2.1

2.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

112

1581

0.70

3.41

1.2

—

(3018010) Neutrophils/100 leukocytes in Blood

2466

23238

1.10

3.38

5.6

5.8

60.5

58.7

11.15

2248

21451

(3033658) Prothrombin time (PT) actual/Normal

1443

13225

1.12

3.38

3.8

4.1

83.6

84.1

0.32

1406

12898

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1015

9111

1.14

3.36

2.0

30.1

0.08

981

8818

(3019069) Monocytes/100 leukocytes in Blood

2465

23239

1.10

3.34

5.9

6.2

8.6

9.0

8.69

2254

21485

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

589

6792

0.85

3.32

4.5

4.9

34.4

33.3

1.66

375

4379

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

246

1954

1.27

3.22

2.0

2.2

g/l

38.1

37.2

1.76

198

1633

(3002030) Lymphocytes/100 leukocytes in Blood

2501

23626

1.10

3.21

5.8

6.1

24.7

25.9

6.51

2264

21682

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

801

7103

1.15

3.18

8.5

8.4

—

(4027681)

185

1.90

3.18

1.5

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2530

23926

1.10

3.16

4.0

4.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

326

2683

1.23

3.12

1.9

ug/l

2.1

2.5

0.29

272

2329

(3000330) Specific gravity of Urine by Test strip

367

3057

1.21

3.12

5.0

3.8

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1320

0.69

3.10

2.3

2.7

mg/l

1.6

1.7

0.78

1169

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4349

44744

0.91

3.10

18.5

17.0

ml/min/173m2

77.1

72.4

48.75

3690

37179

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

950

0.64

3.10

3.8

4.9

iu/ml

914.6

3019.2

—

144

(40760892) CBC W Ordered Manual Differential panel - Blood

1075

9733

1.13

3.09

4.5

4.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

387

3244

1.21

3.08

3.1

3.0

e6/l

0.3

0.19

378

3180

(42870588) Differential panel, method unspecified - Blood

1878

17531

1.10

3.06

5.1

5.7

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

7.51

3.05

1.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

137

1835

0.74

3.05

2.5

4.0

u/ml

73.3

78.8

0.06

132

1755

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

5.00

3.05

1.0

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

181

1395

1.31

3.01

2.3

g/l

127.5

126.9

0.12

149

1004

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

521

1.50

3.00

2.6

2.0

u/field

1.8

1.6

0.11

172

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

0.00

2.95

0.0

1.2

—

117.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

693

0.59

2.95

1.1

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

310

1.65

2.93

1.6

2.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.00

2.93

0.0

2.9

—

7.0

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2919

27848

1.09

2.93

4.4

6.3

umol/l

11.6

12.3

2.52

2736

26360

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

552

4798

1.17

2.90

3.2

4.0

mmol/l

1.2

0.73

472

4178

(3052851) Hemolysis interference index of Serum or Plasma

215

1704

1.27

2.90

3.2

3.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

288

2360

1.23

2.90

2.6

3.2

pmol/l

4.4

4.3

0.44

242

2040

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

135

2.00

2.89

1.3

1.5

pmol/l

13.1

17.2

2.63

109

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

243

1.73

2.89

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

633

7181

0.87

2.88

1.2

1.3

iu/ml

39.2

39.9

0.03

173

2165

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

822

0.63

2.85

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

340

4051

0.83

2.84

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

352

1.60

2.83

1.5

1.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1021

9266

1.12

2.82

2.1

2.6

umol/l

11.5

12.1

1.99

913

8486

(3028717) Thiamine [Mass/volume] in Blood

2.77

2.81

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1258

0.70

2.79

1.3

1.2

—

(3002256) Pathology report gross observation

609

6908

0.87

2.78

1.3

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

131

1.99

2.74

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

1169

0.70

2.71

1.2

titre

248.9

108.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

349

0.46

2.63

1.1

1.0

—

(3042631) Mycobacterium sp identified in Specimen

924

0.67

2.61

2.3

2.8

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

0.00

2.59

0.0

2.7

—

126.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1040

0.69

2.58

1.4

1.7

mg/l

2.1

3.5

1.42

765

(3021901) Oxygen saturation in Capillary blood

156

1207

1.30

2.58

2.6

2.8

—

(3044640) Blood type and Crossmatch panel - Blood

1804

16929

1.09

2.56

2.4

2.6

—

(3008295) Osmolality of Serum or Plasma

549

1.44

2.55

1.5

1.3

mosm/kgh2o

282.7

277.5

0.89

410

(3017509) Phencyclidine [Presence] in Urine

5.46

2.54

1.2

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

100

726

1.38

2.53

3.7

17.4

mmol/l

7.2

7.5

0.66

593

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

449

0.53

2.53

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

315

0.44

2.52

1.0

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

157

1222

1.29

2.49

2.6

2.3

—

(40761536) Microorganisms panel - Urine sediment

488

4258

1.16

2.47

5.8

4.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

793

0.65

2.47

1.1

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

227

1849

1.24

2.47

2.0

2.3

g/l

0.0

0.1

0.20

200

1657

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

311

0.45

2.44

1.0

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

171

1350

1.27

2.44

1.1

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

209

1696

1.24

2.36

2.1

2.3

g/l

0.0

0.00

184

1534

(3048929) Epstein Barr virus Ab [Presence] in Serum

866

0.68

2.34

1.1

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

291

1.58

2.32

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

198

1601

1.24

2.32

1.1

u/ml

2.4

1.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

212

1729

1.23

2.30

2.1

2.3

g/l

0.0

0.50

185

1542

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

126

1.91

2.30

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

106

1406

0.75

2.29

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

256

2131

1.21

2.28

2.0

2.4

g/l

0.3

1.1

6.49

208

1780

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.46

2.27

1.6

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

546

1.42

2.27

1.3

e6/l

103382.7

170987.2

0.39

373

(3006270) Folate [Moles/volume] in Blood

513

1.43

2.26

1.2

nmol/l

307.7

323.2

0.29

401

(3023520) Reticulocytes [#/volume] in Blood

635

5683

1.13

2.24

2.0

2.5

e9/l

62.3

68.4

5.50

501

4338

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.28

2.24

1.1

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

154

1215

1.27

2.23

1.5

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

629

0.63

2.22

1.1

1.2

u/ml

309.8

305.3

0.03

382

(3028300) Cannabinoids [Presence] in Urine

295

1.56

2.21

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

335

1.53

2.21

2.6

2.2

umol/l

14.1

29.0

—

(3003694) ABO and Rh group [Type] in Blood

1292

12018

1.09

2.21

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

566

0.62

2.20

1.3

1.2

—

(40768795) Lymph node Pathology biopsy report

503

0.59

2.18

1.0

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

3.34

2.18

1.1

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

170

1363

1.25

2.17

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

942

8646

1.11

2.13

2.1

2.6

g/l

2.2

2.3

0.19

840

7926

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

280

2368

1.19

2.12

1.9

2.3

g/l

9.8

10.3

1.36

227

1959

(40768441) Liver Pathology biopsy report

333

0.51

2.12

1.1

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

145

1824

0.79

2.11

1.6

titre

76.0

252.4

—

(3024869) Neuronal Ab [Presence] in Serum

116

1.90

2.10

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

318

0.50

2.09

1.9

2.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

170

1371

1.25

2.08

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

933

8572

1.10

2.07

1.2

u/ml

2.0

1.8

0.11

239

2115

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1029

0.73

2.06

1.3

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.32

2.04

1.2

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.18

2.04

1.3

1.2

22.8

51.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

281

2387

1.19

2.04

2.0

1.8

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

197

2385

0.82

2.03

1.3

—

(3027008) Opiates [Presence] in Urine

294

1.53

2.02

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

118

1.87

2.01

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.63

2.00

1.0

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

185

1.68

2.00

2.7

2.9

umol/l

28.1

29.4

0.18

138

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

193

1.66

1.99

1.1

u/l

1.0

1.2

2.10

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

381

3325

1.16

1.98

7.1

9.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

423

3720

1.15

1.97

3.3

3.7

mmol/l

2.4

1.8

2.46

317

2720

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1055

0.74

1.97

1.2

u/ml

3.0

5.6

1.33

172

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

272

1.55

1.97

1.3

1.5

u/l

6.1

6.7

0.16

225

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

295

2526

1.18

1.96

1.9

2.3

g/l

3.7

3.8

1.01

205

1769

(3021589) Normoblasts [#/volume] in Blood

2246

21452

1.07

1.96

11.2

10.5

e9/l

0.0

0.03

1800

17436

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

362

0.55

1.95

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

295

2530

1.17

1.93

1.9

2.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

234

2772

0.84

1.93

1.8

g/l

1.6

1.4

0.31

207

2460

(3021387) Prolactin [Units/volume] in Serum or Plasma

607

1.36

1.92

1.9

1.7

mu/l

292.3

298.8

0.08

564

(3033799) Differential panel - Peritoneal fluid

188

0.42

1.92

2.0

1.8

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

295

2532

1.17

1.91

1.9

2.3

g/l

7.2

7.5

1.32

205

1837

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4416

45090

0.93

1.91

6.4

6.7

mmol/mol

40.7

41.1

2.06

3984

40783

(3004809) Band form neutrophils/100 leukocytes in Blood

1026

0.74

1.91

2.5

3.7

3.0

1.5

0.81

764

(1001926) Buprenorphine [Presence] in Urine by Screen method

227

1.59

1.89

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

5121

50396

1.09

1.88

24.3

21.2

mmol/l

139.7

139.6

1.97

5008

49020

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

442

3915

1.14

1.87

3.4

3.8

kpa

5.2

5.1

1.57

403

3579

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.31

1.87

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1246

13301

0.92

1.87

3.1

3.3

ug/l

0.7

0.8

2.28

901

9672

(1616796) Gas panel - Central venous blood

168

1373

1.23

1.85

3.5

3.9

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

129

1.79

1.85

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1041

0.75

1.83

1.2

u/ml

3.2

0.01

110

(3043410) Blood group antigens tested for on Red Blood Cells

152

1.71

1.82

1.6

1.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

201

1677

1.21

1.81

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

273

2341

1.17

1.81

1.9

2.4

g/l

3.1

0.06

206

1802

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

381

4321

0.87

1.81

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1118

0.76

1.80

1.1

1.2

u/ml

53.9

41.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

101

781

1.30

1.78

1.9

2.1

mg/l

31.7

24.5

0.49

192

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1013

0.75

1.78

1.1

1.3

u/l

31.2

42.9

0.51

876

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

286

0.52

1.77

1.2

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

286

0.52

1.77

1.2

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

286

0.52

1.77

1.2

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

286

0.52

1.77

1.2

1.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

5126

50480

1.09

1.76

24.3

21.3

mmol/l

4.0

9.34

5008

49039

(3038026) Centromere Ab [Units/volume] in Serum

399

0.60

1.75

1.1

1.2

—

61.9

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

117

1.80

1.74

1.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

289

1.49

1.73

1.4

—

(3009343) pH of Capillary blood

434

3862

1.13

1.73

3.4

3.8

7.4

2.30

479

(3003338) MCHC [Mass/volume]

3833

37369

1.07

1.73

27.3

23.6

g/l

331.1

331.4

1.44

3775

36961

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

674

0.69

1.73

1.1

1.4

u/ml

111.8

123.5

0.51

142

(3003434) Protein [Mass/volume] in Pleural fluid

1063

0.76

1.71

1.5

g/l

34.3

31.0

1.73

944

(3016879) Cocaine [Presence] in Urine

275

1.49

1.68

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4587

46701

0.93

1.68

5.0

5.2

mmol/l

6.1

1.83

4059

41450

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

126

1.75

1.67

1.0

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

490

0.65

1.65

1.1

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

490

0.65

1.65

1.1

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

490

0.65

1.65

1.1

1.6

—

(3011288) Drugs identified in Urine by Screen method

188

1.60

1.65

1.3

1.8

—

(3024263) Appearance of Synovial fluid

309

1.46

1.65

1.7

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

361

3187

1.14

1.64

2.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

170

1412

1.21

1.64

2.8

2.9

kpa

7.9

7.8

0.47

165

1296

(3016038) Potassium [Moles/volume] in Urine

393

1.40

1.63

1.1

mmol/l

32.4

35.2

0.58

331

(3012441) Differential panel - Pleural fluid

816

0.73

1.63

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

618

0.69

1.62

2.3

3.6

62.9

58.9

0.43

372

(3019977) pH of Arterial blood

377

1.41

1.62

2.3

2.4

7.4

0.03

141

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

286

1.47

1.61

1.3

1.6

—

(4024509)

592

1.32

1.60

1.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

389

0.62

1.60

1.1

—

87.9

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

569

0.68

1.60

1.2

u/ml

2.4

3.8

0.60

172

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.00

1.59

1.1

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

204

1730

1.19

1.58

6.8

4.4

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

459

0.65

1.56

1.4

1.8

—

2.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

160

1.63

1.55

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

208

1.54

1.53

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

144

0.42

1.50

5.7

7.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

320

0.59

1.49

1.4

1.1

—

(3017732) Neutrophils [#/volume] in Blood

362

3221

1.13

1.48

3.5

3.3

e9/l

4.3

4.2

0.38

239

2283

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

675

0.72

1.47

1.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

605

0.71

1.46

1.0

1.1

g/l

1.5

1.6

0.75

539

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1575

14994

1.07

1.46

2.8

3.3

u/l

31.5

37.1

1.94

1459

14072

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.37

1.45

1.2

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

414

0.65

1.44

1.3

g/l

2.1

2.9

2.70

289

(3024139) IgG subclass 3 [Mass/volume] in Serum

414

0.65

1.44

1.3

g/l

0.4

0.00

287

(3027135) IgG subclass 1 [Mass/volume] in Serum

414

0.65

1.44

1.3

g/l

7.3

7.1

0.08

284

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.13

1.44

1.4

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

899

0.76

1.43

1.2

u/ml

2.5

5.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

294

2589

1.14

1.42

2.0

1.9

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

180

1.56

1.42

3.4

5.8

72.3

71.6

0.04

143

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

133

1.66

1.42

1.6

1.5

ug/l

0.4

0.24

(3028679) Herpes simplex virus Ab [Presence] in Serum

149

1.61

1.40

1.0

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

202

2347

0.86

1.40

2.6

2.8

u/ml

0.4

0.3

1.27

125

1348

(3005719) IgG [Mass/volume] in Serum or Plasma

313

3523

0.88

1.38

2.7

g/l

10.1

10.6

1.24

277

3181

(3015235) Bicarbonate [Moles/volume] in Capillary blood

192

1643

1.17

1.37

2.7

3.1

mmol/l

25.7

24.9

1.65

179

1419

(40768806) Pleura Pathology biopsy report

814

0.76

1.37

1.7

1.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

123

0.41

1.36

4.8

7.9

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

627

5778

1.09

1.36

2.4

ug/l

6.2

6.8

0.43

472

4954

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

162

0.49

1.35

1.0

1.2

—

(3044007) Cell count panel - Peritoneal fluid

164

0.49

1.35

2.8

1.8

—

(3047189) Immunofixation for 24 hour Urine

321

0.62

1.32

1.4

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

216

1.48

1.32

2.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

684

0.74

1.32

1.7

1.5

59.1

62.8

0.29

436

(3009445) Proteinase 3 Ab [Units/volume] in Serum

204

2352

0.86

1.30

1.6

u/ml

24.5

18.8

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.35

1.29

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

132

0.45

1.28

1.5

1.3

g/l

31.6

27.5

—

103

(3000991) Gas panel - Venous blood

547

5027

1.10

1.27

5.6

7.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

588

0.73

1.27

1.0

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

210

1.48

1.27

1.6

1.5

u/l

1.4

57.7

1.36

(3048879) Bone marrow aspiration report

192

0.52

1.27

1.0

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

107

1.68

1.25

1.1

—

(3016228) CD19 cells/100 cells in Blood

191

0.52

1.25

2.1

1.9

3.7

7.1

—

179

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

219

1.46

1.25

1.1

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

551

0.72

1.24

1.2

u/ml

2.6

4.8

1.95

247

(3014133) Dog dander IgE Ab [Units/volume] in Serum

216

0.55

1.24

1.0

u/ml

1.0

2.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

810

0.78

1.22

1.6

1.7

—

(4268621)

373

0.67

1.21

2.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

201

0.55

1.20

1.0

u/ml

0.5

1.9

—

(3020779) Urea [Moles/volume] in Serum or Plasma

519

5631

0.91

1.18

4.5

6.8

mmol/l

10.3

11.2

1.99

473

5325

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

485

4451

1.10

1.18

2.8

3.8

ng/l

86.1

98.6

1.33

391

3749

(40761511) CBC panel - Blood by Automated count

4903

48392

1.06

1.17

19.7

17.1

—

(3042936) Bacteria identified in Isolate by Culture

842

7909

1.07

1.17

2.0

—

(40768443) Skin Pathology biopsy report

209

2384

0.87

1.17

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

125

1.60

1.17

1.1

—

(3045424) Erythrocytes [Presence] in Urine

104

857

1.22

1.17

1.4

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

623

1.26

1.16

2.6

3.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

1.16

0.0

3.6

—

(3017569) Oxygen content in Arterial blood

342

1.35

1.15

2.2

2.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

508

0.73

1.15

1.1

1.2

miu/ml

98.1

183.6

—

155

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

101

1220

0.82

1.14

2.6

2.4

183.6

209.8

2.64

1160

(3010421) pH of Blood

182

1579

1.16

1.14

4.0

4.5

7.4

0.30

150

1345

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

222

0.58

1.13

1.4

1.9

—

(3045142) Bone marrow Pathology biopsy report

677

0.77

1.13

1.0

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

110

1316

0.83

1.13

2.1

91.5

87.7

1.01

104

1249

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1108

0.82

1.12

1.3

1.5

—

(4062490)

413

0.70

1.12

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

440

1.30

1.12

1.3

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

866

8158

1.07

1.12

2.2

2.7

21.1

21.7

0.52

694

6845

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

221

0.59

1.12

1.2

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

221

0.59

1.12

1.2

1.9

—

(21494890) Protein electrophoresis panel - 24 hour Urine

698

0.77

1.11

1.8

2.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

146

1249

1.17

1.10

4.4

3.7

mg/l

28.7

30.2

0.18

811

(3027456) Digoxin [Moles/volume] in Serum or Plasma

134

1572

0.85

1.10

3.1

nmol/l

0.8

1.31

101

1188

(3002385) Erythrocyte distribution width [Ratio]

3834

37626

1.05

1.09

24.2

21.6

13.8

13.9

7.20

3736

36685

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

363

1.32

1.09

1.1

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

158

1362

1.16

1.09

1.8

1.6

e6/l

13309.0

15705.4

0.34

122

967

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

138

0.51

1.09

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

650

0.77

1.08

3.2

4.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

152

1.51

1.08

1.5

1.1

—

(40768446) Kidney Pathology biopsy report

163

0.55

1.08

1.3

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

108

1287

0.84

1.07

2.4

3.2

u/ml

253.7

799.0

1.29

1171

(3020491) Glucose [Moles/volume] in Blood

383

1.31

1.05

2.2

mmol/l

7.8

7.1

0.62

256

(40757373) Influenza virus identified in Isolate

129

1.55

1.05

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

122

0.49

1.05

1.8

1.5

ug/l

10.6

9.5

—

122

(21494814) CD8 cells/100 lymphocytes in Specimen

179

0.56

1.04

2.1

1.9

—

(3023199) Leukocytes [#/volume] in Pleural fluid

922

0.81

1.03

1.5

e6/l

2920.8

1932.0

0.37

664

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

532

0.75

1.03

1.1

1.6

—

(3000494) Fungus identified in Specimen by Culture

614

5733

1.08

1.02

1.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

107

0.47

1.00

1.0

1.2

—

94.9

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

616

5759

1.08

1.00

3.1

ng/l

220.2

246.3

0.90

558

5300

(3006922) Hepatitis E virus Ab [Presence] in Serum

250

0.64

1.00

1.2

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

116

984

1.18

0.99

1.9

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

449

1.27

0.99

1.3

1.4

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

651

0.78

0.98

3.9

3.5

nmol/l

3.5

16.8

0.92

636

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

300

1.34

0.98

2.0

1.8

u/field

1.1

2.2

1.58

198

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.17

0.98

1.2

1.6

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.1

—

1.9

—

(3024316) Viscosity of Plasma

0.00

0.97

0.0

1.6

—

1.7

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

486

1.26

0.97

1.4

1.3

iu/l

32.4

33.5

0.09

410

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.63

0.97

2.3

1.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

100

1.60

0.96

1.2

1.3

110.9

112.1

0.05

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

165

1.46

0.96

1.2

1.4

umol/l

109.7

98.9

—

101

(3005322) IgE [Units/volume] in Serum or Plasma

200

2250

0.89

0.95

1.3

u/ml

440.2

232.3

0.53

178

2039

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

805

1.20

0.95

5.8

6.3

mg/l

12.4

12.2

0.10

737

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

340

3108

1.10

0.94

1.5

1.7

g/l

1.6

0.15

283

2659

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

478

0.75

0.94

1.0

1.1

u/ml

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

120

0.50

0.93

1.2

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.82

0.92

3.8

2.7

u/field

0.6

0.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2888

28234

1.04

0.92

3.1

3.2

u/l

48.8

56.9

2.84

2616

25481

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

196

0.61

0.92

1.2

1.4

37.5

23.4

0.66

161

(3028308) Erythrocytes [#/volume] in Pleural fluid

842

0.82

0.91

1.5

e6/l

78575.3

70016.8

0.11

496

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

111

1296

0.85

0.91

1.4

1.6

iu/ml

0.4

10.9

1.20

310

(46235355) HIV 1 and 2 tests - Meaningful Use set

404

4368

0.92

0.90

1.4

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

231

0.65

0.90

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

231

0.65

0.90

1.1

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

290

0.69

0.89

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

290

0.69

0.89

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

290

0.69

0.89

1.2

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

174

1538

1.14

0.89

1.4

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

206

0.63

0.88

1.2

1.3

—

(3001729) Color of Synovial fluid

1.79

0.87

1.4

—

(3034426) Prothrombin time (PT)

130

0.54

0.87

1.4

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

181

0.61

0.87

1.6

2.0

e6/l

1361.0

19031.4

—

103

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.61

0.87

1.2

—

(3025941) Bacteria identified in Stool by Culture

267

2424

1.11

0.87

1.3

—

(3012565) Volume of 24 hour Urine

264

0.68

0.86

1.3

2.3

2419.2

1830.6

1.22

218

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

174

1958

0.89

0.86

1.5

1.7

u/l

37.3

38.2

0.26

149

1663

(3019225) pH of Specimen

627

5907

1.07

0.85

4.0

4.6

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

286

0.70

0.84

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

286

0.70

0.84

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

286

0.70

0.84

1.2

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

239

0.67

0.84

1.2

1.3

ug/l

13.5

475.0

—

119

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

512

0.78

0.82

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

188

1.38

0.82

2.3

2.0

umol/l

55.5

56.8

0.05

147

(3016650) Hepatitis A virus Ab [Presence] in Serum

634

0.80

0.82

1.1

—

(1002224) Polysomnography panel

1132

0.85

0.81

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

307

0.72

0.81

1.0

u/ml

0.9

1.1

—

119

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

105

1.53

0.81

1.2

1.3

73.4

78.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

225

0.67

0.81

1.9

2.5

—

(40767503) Oxygen content in Capillary blood by calculation

152

1343

1.14

0.81

3.1

2.5

16.3

15.9

0.88

103

697

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

1.70

0.80

1.5

1.1

—

23.7

—

(3048689) Calprotectin [Mass/mass] in Stool

493

4619

1.07

0.79

1.9

2.0

ug/g

200.0

166.1

0.84

396

3554

(3002179) Metamyelocytes/100 leukocytes in Blood

377

4060

0.92

0.79

3.0

3.8

0.9

0.7

0.52

965

(3000570) Elastase.pancreatic [Mass/mass] in Stool

176

1572

1.12

0.79

1.4

ug/g

276.2

262.3

0.41

108

963

(3017704) Immunofixation for Urine

385

0.75

0.79

1.2

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

270

0.70

0.78

2.9

2.5

37.3

37.0

—

104

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

966

0.85

0.78

1.3

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

131

1.45

0.78

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.50

0.77

4.8

7.6

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.77

0.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.77

0.0

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

824

0.84

0.77

1.3

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

612

1.20

0.76

1.1

1.3

pmol/l

245.1

261.1

0.20

464

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.76

0.0

3.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

120

1369

0.87

0.76

1.3

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.70

0.75

1.0

1.1

—

(3012501) Base excess in Blood by calculation

154

1370

1.13

0.75

4.1

4.6

mmol/l

2.5

2.7

0.30

124

933

(3027315) Oxygen [Partial pressure] in Blood

155

1381

1.13

0.74

4.1

4.7

kpa

8.2

8.4

0.41

150

1353

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

312

0.74

0.73

2.9

1.9

16.3

14.6

0.23

122

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

160

0.62

0.73

2.1

1.9

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

102

884

1.16

0.73

1.1

—

(3011985) Renin [Units/volume] in Plasma

662

1.18

0.72

1.2

1.4

mu/l

33.1

58.4

1.46

586

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.00

0.72

1.0

1.1

—

(3044889) 12 lead EKG panel

3587

35328

1.04

0.72

4.3

4.4

—

(3008898) HLA-B27 [Presence]

892

0.85

0.71

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.75

0.71

1.6

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

682

7164

0.95

0.70

2.6

4.0

u/l

232.0

248.1

2.81

630

6713

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

126

1.43

0.70

1.2

1.1

miu/ml

1359.7

1639.2

0.41

126

(3036782) Glucose [Moles/volume] in Pleural fluid

695

0.83

0.69

1.4

mmol/l

5.8

6.4

1.03

639

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

305

2825

1.08

0.69

2.9

3.9

mmol/l

24.9

24.1

4.03

255

2521

(21494434) Karyotype in Bone marrow

553

0.81

0.69

1.1

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

116

1315

0.88

0.69

1.3

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

154

1715

0.90

0.68

1.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

408

3824

1.07

0.68

1.6

1.7

1.5

1.6

2.12

349

3161

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

506

4777

1.06

0.68

2.3

2.4

u/l

39.0

38.7

0.01

416

4063

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

102

1.47

0.67

1.2

1.1

79.4

80.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

363

0.77

0.67

1.1

u/ml

0.2

1.6

—

137

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2385

23345

1.03

0.67

4.9

5.5

ug/l

4.7

4.0

0.26

2103

20671

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1918

18703

1.04

0.67

4.5

4.8

22.3

22.1

0.21

995

10086

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

105

920

1.14

0.67

1.3

1.7

iu/l

4.6

4.2

0.13

268

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

493

1.20

0.66

1.7

u/ml

35.3

26.1

0.70

112

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

351

0.77

0.66

2.5

3.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1335

12930

1.04

0.66

2.3

2.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.53

0.66

1.0

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

560

0.82

0.65

1.1

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

171

1.35

0.65

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

189

1.32

0.64

1.6

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

189

1.32

0.64

1.6

2.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

224

0.71

0.64

1.1

1.2

—

(3019174) dRVVT (LA screen)

1.72

0.64

1.0

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

256

2365

1.09

0.63

3.8

4.2

mmol/l

25.4

24.8

2.99

226

2145

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

235

0.72

0.63

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

546

0.82

0.63

3.0

3.1

mg/l

43.1

29.9

0.40

410

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

115

1294

0.89

0.62

1.6

1.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.63

0.62

1.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

501

0.82

0.61

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.67

0.61

1.0

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

182

1.32

0.61

1.0

1.4

umol/l

27.5

22.2

0.35

173

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

244

1.27

0.61

1.3

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

517

1.18

0.61

1.6

1.4

25.2

27.2

0.17

324

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

759

0.85

0.60

1.2

1.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.54

0.59

1.0

—

(36660697) Celiac disease serology panel - Serum

328

3071

1.07

0.59

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

209

2270

0.92

0.59

2.8

2.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

114

1.40

0.58

1.3

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

310

0.77

0.58

1.0

u/ml

1.1

3.0

—

136

(3044927) Protein electrophoresis panel - Urine

706

1.15

0.58

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

464

0.82

0.58

1.4

1.2

mmol/l

8.1

7.8

0.29

331

(3024928) Oxygen saturation in Venous blood

136

1226

1.11

0.57

1.9

2.9

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.71

0.57

1.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

4026

40700

0.97

0.57

22.4

19.3

37.4

38.5

6.87

2303

24837

(3024980) IgG subclass 4 [Mass/volume] in Serum

669

0.85

0.57

1.9

1.5

g/l

0.5

0.9

3.29

498

(40760888) Immunoglobulin light chains.free panel - Serum

149

1641

0.91

0.57

2.2

3.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

930

8973

1.04

0.57

25.4

30.3

inr

1.4

1.5

0.55

1222

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

517

0.83

0.56

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.56

0.55

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.62

0.55

1.0

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

206

0.73

0.55

4.1

4.6

—

60.9

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

107

1.40

0.55

1.2

1.3

g/l

0.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

110

1228

0.89

0.55

1.6

1.8

mg/l

10.6

12.6

1.73

103

1119

(3017446) Testosterone [Moles/volume] in Serum or Plasma

346

3672

0.94

0.54

1.8

2.1

nmol/l

12.3

11.9

0.41

295

3138

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

793

0.87

0.54

1.2

1.4

—

(3044941) Cell count panel - Synovial fluid

862

1.13

0.53

1.5

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.54

0.53

1.2

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

545

0.84

0.52

1.3

1.2

u/l

53.8

64.7

0.96

363

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.52

0.52

1.3

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

260

0.77

0.52

1.6

1.4

1.6

3.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

133

1207

1.10

0.51

1.3

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.41

0.51

1.3

1.2

—

(3002619) Bacteria identified in Specimen by Culture

109

1.38

0.50

1.6

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

724

0.87

0.50

1.3

u/l

322.8

336.9

0.09

682

(3011648) Oxygen content in Venous blood

423

0.83

0.50

1.3

1.8

10.5

10.8

0.14

423

(4306422)

508

0.85

0.49

1.1

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.56

0.48

1.1

1.4

—

(3021788) Differential panel - Synovial fluid

986

0.89

0.48

1.6

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

108

0.65

0.48

1.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

662

1.13

0.48

1.4

1.3

nmol/l

0.7

0.2

3.63

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

528

0.85

0.47

1.6

1.4

u/l

12.8

13.0

0.08

503

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.49

0.47

1.3

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.49

0.47

1.3

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.49

0.47

1.3

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

792

7654

1.04

0.47

1.4

1.5

g/l

2.5

2.7

1.52

405

4340

(3003458) Phosphate [Moles/volume] in Serum or Plasma

788

7615

1.04

0.47

3.7

5.7

mmol/l

1.0

4.05

713

7012

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

321

0.81

0.46

1.4

1.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

227

1.23

0.46

1.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

633

0.87

0.46

3.9

3.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

364

0.82

0.46

1.5

—

(3026470) Cobalt [Mass/volume] in Blood

428

0.84

0.45

1.8

1.9

ug/l

3.9

3.6

0.10

367

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

363

0.83

0.45

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.40

0.45

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.40

0.45

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

140

1.29

0.41

1.6

1.2

—

(3035880) pH of Pleural fluid

424

0.85

0.41

1.4

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.41

0.0

1.1

—

8.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.41

0.0

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

272

0.81

0.41

1.2

1.1

u/l

75.0

88.2

0.41

207

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

272

0.81

0.41

1.2

1.1

u/l

21.4

33.1

0.92

203

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.41

0.0

2.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.41

0.0

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.40

0.0

10.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.40

0.0

1.2

—

3.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.47

0.40

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

260

0.81

0.40

1.7

1.4

u/ml

0.9

1.6

0.29

143

(3051611) Lipemic interference index of Serum or Plasma

625

1.12

0.40

2.9

3.4

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

171

0.76

0.39

2.5

2.1

u/l

19.5

49.5

1.22

157

(3036071) Salmonella sp Ab [Titer] in Serum

105

0.67

0.39

1.3

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.41

0.39

1.3

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

191

1790

1.07

0.39

1.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

313

0.83

0.38

1.4

1.2

u/l

96.3

91.0

0.13

269

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

178

1.24

0.38

1.4

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

142

1.27

0.38

1.1

—

(4094501)

122

1322

0.92

0.38

1.1

—

(3023419) Bacteria identified in Sputum by Culture

769

0.90

0.38

2.0

2.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

580

1.12

0.38

1.5

1.3

nmol/l

—

(3037556) Urate [Mass/volume] in Serum or Plasma

192

0.78

0.38

1.7

1.5

—

(3000285) Sodium [Moles/volume] in Blood

1.35

0.37

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

317

1.17

0.37

1.3

promille

0.5

1.1

2.50

242

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4983

50093

0.97

0.37

10.1

11.5

u/l

19.4

25.3

111.22

4671

47848

(40765096) Chromosome analysis panel by Banding

180

0.78

0.36

1.2

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

244

1.19

0.36

1.4

1.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

189

1.22

0.36

1.2

—

(3025315) Body weight

1.43

0.35

6.3

5.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

502

5199

0.96

0.35

2.0

2.1

g/l

0.2

0.09

459

4792

(3017181) Myelocytes/100 leukocytes in Blood

434

4506

0.96

0.34

3.2

3.9

0.8

1.0

0.44

104

1377

(3021440) Promyelocytes/100 leukocytes in Blood

411

4272

0.96

0.34

3.3

3.9

0.2

0.1

0.21

1282

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

145

0.76

0.34

2.8

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

330

0.85

0.34

1.7

1.5

u/l

1.9

6.8

—

155

(3045788) Cell count panel - Pleural fluid

710

0.90

0.34

1.6

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

349

1.15

0.33

1.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

667

0.90

0.33

1.4

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.30

0.33

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.30

0.31

1.7

1.4

umol/l

3.6

2.4

1.29

(3025577) Chromium [Mass/volume] in Blood

411

0.88

0.31

1.9

2.0

ug/l

2.4

2.1

0.20

341

(3013139) Helicobacter pylori Ag [Presence] in Stool

319

3064

1.04

0.30

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

600

1.10

0.30

1.4

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

205

2156

0.95

0.30

1.2

iu/ml

70.9

126.1

2.34

724

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

102

1.28

0.30

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

128

1365

0.94

0.29

2.1

2.3

g/l

3.6

0.01

117

1296

(21491868) Cryoglobulin [Mass/volume] in Serum

174

0.80

0.29

1.1

1.2

g/l

—

0.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

174

0.80

0.29

1.1

1.4

umol/l

4.8

13.1

—

109

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

157

1.21

0.29

1.4

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.25

0.29

2.4

12.2

—

(3022689) Creatine [Moles/volume] in Urine

141

0.78

0.29

1.4

1.5

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

107

0.75

0.29

1.0

1.1

—

4.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

888

0.92

0.28

1.6

1.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

302

0.86

0.28

1.4

1.2

u/l

20.1

25.6

0.34

253

(4146454)

689

0.91

0.27

2.6

2.8

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

139

0.79

0.26

1.1

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

309

1.13

0.26

1.2

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

309

1.13

0.26

1.2

1.4

—

(3014891) Appearance of Pleural fluid

104

1.25

0.26

1.7

1.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

319

1.13

0.26

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

896

1.07

0.26

1.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

149

0.80

0.25

1.0

1.3

40.9

33.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

396

1.11

0.25

1.1

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.23

0.25

1.0

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

425

1.11

0.25

1.3

1.4

titre

1096.4

197.9

0.79

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.22

0.25

1.1

1.2

—

(3004451) EKG impression Narrative

330

1.12

0.25

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

105

1.24

0.24

1.3

1.5

ng/l

77.1

146.3

2.59

105

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

308

0.88

0.24

2.9

1.9

—

(40768797) Stomach Pathology biopsy report

716

7008

1.02

0.24

1.2

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.74

0.24

1.0

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

725

1.08

0.24

1.6

1.9

pmol/l

187.2

196.9

0.44

670

(3038177) Helicobacter pylori Ab [Presence] in Serum

558

0.91

0.23

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

322

1.12

0.23

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

322

1.12

0.23

1.3

1.4

—

(3036603) Volume of Urine

359

0.89

0.23

1.2

1.7

1707.9

1794.3

0.11

102

(3022313) Gas panel - Capillary blood

289

2793

1.04

0.23

3.6

3.9

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.28

0.23

1.0

1.1

—

(3024731) MCV [Entitic volume]

5163

51460

1.02

0.22

29.8

26.0

91.8

0.16

5074

50422

(3035941) MCH [Entitic mass]

5163

51460

1.02

0.22

29.7

26.0

30.4

30.5

1.21

5074

50422

(3000963) Hemoglobin [Mass/volume] in Blood

5164

51471

1.02

0.22

30.1

26.3

g/l

130.6

133.2

28.68

5077

50443

(3026361) Erythrocytes [#/volume] in Blood

5163

51462

1.02

0.21

29.9

26.1

e12/l

4.3

4.4

18.85

4996

49601

(3000012) Reticulocyte production index

357

0.90

0.21

1.4

1.5

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

1.9

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

1316.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

5.6

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

0.2

—

(3007461) Platelets [#/volume] in Blood

5162

51454

1.02

0.21

29.9

26.1

e9/l

237.7

239.0

0.73

5022

49795

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

4.4

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.0

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

1.9

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

3.6

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

2.3

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

30.6

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

0.4

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

1.2

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

0.4

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

4.9

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

5.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

105

0.76

0.21

1.0

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

145

0.83

0.21

1.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.21

0.0

6.3

—

42.5

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.20

0.0

5.9

—

378.6

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.20

0.0

1.0

—

1.1

—

(3013762) Body weight Measured

0.00

0.20

0.0

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

586

1.08

0.20

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.25

0.20

1.0

1.2

u/l

40.7

11.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.25

0.20

1.0

—

(3026726) Creatinine [Moles/volume] in Specimen

1.22

0.20

2.5

umol/l

167.3

587.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

121

1152

1.05

0.19

1.9

1.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

338

3288

1.03

0.19

5.9

8.3

mmol/l

24.6

24.3

0.95

310

3024

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

918

1.06

0.19

2.1

3.2

—

(3013512) EKG study

1666

16831

0.99

0.19

4.8

4.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

929

1.06

0.19

1.4

nmol/l

0.7

0.8

0.81

762

(3035320) C reactive protein [Mass/volume] in Body fluid

366

1.09

0.18

2.9

2.6

—

(3010813) Leukocytes [#/volume] in Blood

5162

51474

1.02

0.18

29.9

26.1

e9/l

6.9

0.69

4998

49598

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

575

5860

0.98

0.18

2.3

2.7

umol/l

8.1

9.5

1.02

497

5101

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

159

1529

1.04

0.18

1.7

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

185

1.14

0.18

1.3

1.2

—

(3025159) Blasts/100 leukocytes in Blood

388

3970

0.98

0.17

3.4

4.0

1.2

0.2

0.40

1067

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

640

0.94

0.17

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

131

0.84

0.17

1.2

1.8

—

(3015183) Erythrocyte sedimentation rate

120

0.83

0.16

1.0

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.16

0.16

1.3

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

699

0.94

0.16

1.2

1.3

u/l

9.9

11.2

0.46

566

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

111

1.17

0.15

1.1

1.5

—

(3028433) Virus identified in Specimen by Culture

172

0.87

0.15

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.79

0.15

1.7

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

633

1.06

0.15

1.1

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.75

0.15

13.3

14.3

mmol/l

5.4

5.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

780

0.95

0.15

1.1

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

140

0.86

0.15

1.7

2.4

—

(3051651) Icteric interference index of Serum or Plasma

338

0.92

0.15

2.8

3.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.08

0.14

1.1

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

120

1155

1.04

0.14

1.5

—

(44806118)

583

0.94

0.14

1.3

1.4

—

(44790047)

583

0.94

0.14

1.3

1.4

—

(44790048)

583

0.94

0.14

1.3

1.4

—

(44790049)

583

0.94

0.14

1.3

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

100

0.80

0.13

1.0

1.2

—

(3049717) Cytology report of Urine Cyto stain

283

2768

1.02

0.13

2.2

2.9

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

180

1.11

0.13

1.1

1.2

ratio

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

127

0.87

0.12

1.3

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

100

1038

0.96

0.12

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

417

4239

0.98

0.12

3.1

2.8

ml/min/173m2

65.3

59.9

1.86

163

1812

(3020961) Endomysium IgA Ab [Titer] in Serum

162

1666

0.97

0.12

1.1

titre

682.2

244.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

241

0.91

0.12

1.0

3.8

mg/l

57.5

67.9

—

169

(3045683) HLA typing for celiac disease panel - Blood or Tissue

162

1.11

0.11

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

867

1.04

0.11

1.4

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

159

1548

1.03

0.11

1.4

—

(3037121) Protein [Mass/volume] in Urine

203

1984

1.02

0.11

2.2

3.0

g/l

0.2

0.3

2.62

822

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

465

1.05

0.11

1.1

—

(4015189)

183

1.09

0.10

1.9

2.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

214

2182

0.98

0.09

2.1

3.2

mg/l

32.6

54.8

2.34

177

1779

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

133

1296

1.03

0.09

1.4

1.5

g/l

1.1

1.2

0.36

126

1224

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.09

0.08

1.8

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

654

0.96

0.08

1.3

1.4

—

(3016330) Potassium [Moles/time] in 24 hour Urine

1.05

0.08

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.05

0.08

1.3

1.8

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

267

0.94

0.08

1.7

1.2

nmol/l

1.2

0.02

198

(4212803)

0.82

0.08

1.0

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.78

0.08

1.0

1.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.77

0.08

1.2

1.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.09

0.08

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.09

0.08

1.4

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

154

0.91

0.08

2.0

1.8

—

(4211845)

283

1.06

0.08

3.6

3.8

—

(44806420)

215

0.93

0.07

2.5

2.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

215

2185

0.98

0.07

2.1

3.2

mg/l

49.2

89.5

0.89

179

1782

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.05

0.07

1.3

1.2

mg/l

6.7

7.8

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.05

0.07

1.0

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

101

986

1.02

0.07

1.3

1.4

—

(3045716) Anion gap in Serum or Plasma

295

1.05

0.06

2.1

2.2

mmol/l

7.7

9.3

2.42

234

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

142

0.92

0.06

2.2

2.3

mmol/l

6.4

7.7

—

(3020650) Glucose [Presence] in Urine

102

0.88

0.06

1.3

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

443

1.04

0.06

1.3

1.2

—

(3004775) Volume in Urine collected for unspecified duration

497

0.97

0.06

2.1

2.2

538.5

656.7

1.45

301

(3022806) Fractional oxyhemoglobin in Capillary blood

810

0.97

0.06

2.4

1.9

89.1

89.0

0.07

801

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

162

0.93

0.06

1.1

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

709

0.97

0.06

1.3

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

365

0.96

0.06

1.2

titre

63.3

120.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

294

0.95

0.06

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

243

0.95

0.05

1.3

1.4

pmol/l

124.2

167.1

0.16

(42529582) MDA5 Ab [Presence] in Serum by Line blot

129

1.09

0.05

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

129

1.09

0.05

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

129

1.09

0.05

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

129

1.09

0.05

1.0

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

583

1.03

0.05

1.3

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

326

1.04

0.05

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

326

1.04

0.05

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

161

1586

1.02

0.05

1.1

1.2

u/ml

1.9

1.2

0.27

161

(3025468) Yersinia sp identified in Specimen by Organism specific culture

706

0.98

0.04

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

706

0.98

0.04

1.3

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

123

1211

1.02

0.04

1.1

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

514

0.97

0.04

1.4

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

302

0.96

0.04

1.1

1.2

mmol/l

10.4

12.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

298

1.04

0.04

2.5

3.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

554

0.97

0.04

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

109

0.92

0.04

3.2

1.9

ug/l

1.6

1.2

—

101

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

392

0.97

0.04

1.2

1.0

u/ml

4.5

2.5

—

103

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

703

0.98

0.03

1.3

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

149

1504

0.99

0.02

2.2

2.3

ug/min

111.7

96.6

0.25

859

(3006462) Nitrate [Presence] in Urine

261

1.03

0.02

3.9

4.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

811

0.99

0.02

1.3

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

127

1258

1.01

0.02

1.4

1.5

g/l

0.2

0.06

120

1190

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

214

2127

1.01

0.02

2.0

3.1

ratio

1.4

3.5

1.43

153

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

258

0.97

0.02

1.6

g/l

0.9

0.97

258

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

113

1.06

0.01

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

709

0.99

0.01

1.3

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

719

0.99

0.01

1.3

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

207

0.97

0.01

1.1

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

887

0.99

0.01

1.3

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

414

1.01

0.00

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

102

1014

1.01

0.00

2.5

3.7

59.3

58.9

0.13

102

1014

(3036670) Protein [Mass/volume] in Synovial fluid

200

1.00

0.00

1.3

1.2

g/l

40.9

40.4

0.08

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

389

1.00

0.00

1.3

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

252

0.99

0.00

1.2

—

(3037756) Immunofixation for Serum or Plasma

146

1456

1.00

0.00

1.3

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

250

1.00

0.00

6.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

254

0.98

0.00

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

119

1.01

0.00

4.3

6.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

630

1.00

0.00

1.0

1.1

iu/ml

38.6

314.3

0.53

122

(3010838) Calcium [Moles/time] in 24 hour Urine

248

1.01

0.00

1.7

—

8.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

101

0.99

0.00

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

349

1.00

0.00

1.1

—

(3036489) Thrombin time

173

1728

1.00

0.00

2.0

1.9

21.6

21.8

0.12

155

1557

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

338

1.01

0.00

4.8

5.0

u/ml

61.4

47.2

0.19

(3016750) Collection duration of Urine

342

0.99

0.00

1.8

2.0

min

502.4

492.9

0.19

232

(3051593) INR in Capillary blood by Coagulation assay

370

1.00

0.00

7.3

13.6

—

(4133840)

1.03

0.00

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

855

0.99

0.00

1.4

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

255

0.98

0.00

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

236

1.02

0.00

1.8

1.7

—

(44813793)

236

1.02

0.00

1.0

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

133

0.98

0.00

1.0

1.5

umol/l

1.9

0.10

123

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.91

0.00

1.6

4.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

4.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3021374) Sirolimus [Mass/volume] in Blood

0.00

0.0

7.0

—

7.2

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

25.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.00

0.00

1.2

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.2

—

3230.0

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

5.8

—

14.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

3.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.0

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.86

0.00

2.2

1.7

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.92

0.00

1.0

1.2

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: G6_PARKINSON_INCLAVO – Parkinson's disease, including avohilmo

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Parkinson's disease, including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Case counts by code for Parkinson's disease, including avohilmo (G6_PARKINSON_INCLAVO)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints